Systems and methods for sample analysis - Patents.com
Assay surfaces and processing units using magnetic forces and digital detection enhance sample analysis sensitivity and throughput, addressing the inefficiencies of existing systems by reducing preparation time and sample volumes.
Patent Information
- Application Number
- JP2024524627
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-11-03
- Filing Date
- 2022-11-03
- Publication Date
- 2024-11-13
AI Technical Summary
Existing sample analysis systems face challenges in achieving high sensitivity and reduced processing time due to inadequate automation, lengthy sample preparation times, and inefficient detection methods, particularly in laboratory and point-of-care settings.
The development of assay surfaces and processing units that utilize magnetic forces to move solid supports through sample preparation regions, incorporating digital detection components for enhanced sensitivity and reduced sample volumes, allowing for rapid analyte detection and analysis.
This approach significantly reduces sample preparation time, increases sensitivity, and enables high-throughput analysis, with the ability to detect multiple samples in less than 6 minutes and up to 600 samples per hour per square meter, while using smaller sample and reagent volumes.
Smart Images

Figure 2024541917000001_ABST
Abstract
Description
[Technical field]
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 63 / 275,359, filed November 3, 2021, which is incorporated by reference herein in its entirety for all purposes.
[0002] The subject matter of the present disclosure relates to devices, systems and methods for the preparation, detection and analysis of analytes of interest in a sample with improved sensitivity and reduced processing times. [Background technology]
[0003] Methods and devices capable of accurately analyzing one or more analytes of interest in a sample can be beneficial for applications involving diagnostics, prognosis, environmental assessment, food safety, detection of chemical or biological agents, etc. Such methods and devices can be configured not only for accuracy, precision and / or sensitivity, but also to allow individual samples of interest to be analyzed in less time and with a reduced instrumentation footprint.
[0004] Sample preparation techniques in systems for sample analysis may include preparing the sample, such as, but not limited to, combining the sample with reagents and / or enzymes in a reaction vessel. In known commercial laboratory systems for sample analysis, the sample processing time to prepare the sample for detection and analysis may take up to 20 minutes or more. This duration of sample preparation time may be due, at least in part, to the lack of suitable automation systems to prepare different samples for performing a variety of different assays. The amount of sample and / or the amount of reagents used to obtain a suitable signal for detection may also affect the sample preparation time. Furthermore, achieving an appropriate concentration of the analyte within the sensitivity and detection range of conventional detection systems and methods may involve increased incubation or amplification times, thereby further increasing the time to detect the analyte of interest.
[0005] Techniques for sample detection in systems for sample analysis may include using or incorporating analog detection systems and methods. The sensitivity and detection range of such analog systems and methods may be factors that determine the sample size and / or processing time used to achieve an appropriate concentration of analyte within the sensitivity and detection range of the sample detection device. Thus, there is interest in methods and devices for sample detection that reduce processing time and improve detection sensitivity.
[0006] It would also be beneficial if the methods and devices for sample detection could be prepared in smaller volumes and / or with reduced sample processing times, and it would also be beneficial if the methods and devices for sample detection automated the sample processing and detection process and provided highly sensitive detection of an analyte of interest in a sample for use in a laboratory environment, such as, but not limited to, a clinical laboratory or a point-of-care laboratory environment. Summary of the Invention [Problem to be solved by the invention]
[0007] Thus, there remains potential for methods and devices for sample detection that can achieve increased throughput due, at least in part, to reduced sample preparation time and / or increased sensitivity of sample processing and detection systems. [Means for solving the problem]
[0008] overview Disclosed herein are systems, devices and methods for the analysis of an analyte of interest in a sample. According to one aspect of the disclosure, disclosed herein is an assay surface (AS) for the analysis of an analyte of interest in a sample and a method of using the AS for the analysis of an analyte of interest. According to another aspect of the disclosure, disclosed herein is an assay processing unit (APU) for sample processing and analyte detection on an assay surface and a method of using the APU for the analysis of an analyte of interest. According to another aspect of the disclosure, disclosed herein is an assay processing system (APS) for the analysis of an analyte of interest in a sample and a method of using the APS for the analysis of an analyte of interest. According to another aspect of the disclosure, disclosed herein is a laboratory system for the analysis of one or more analytes of interest in a plurality of samples and a method of using such a laboratory system. According to another aspect of the disclosure, disclosed herein is a laboratory system having a shorter processing time and / or a higher throughput and a method of using the laboratory system.
[0009] According to one aspect of the present disclosure, an assay surface (AS) can include a sample processing component configured to process a sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, and a detection component configured to receive the plurality of solid supports by magnetic force and to detect the presence of an analyte or determine a level or concentration of the analyte.
[0010] Additionally or alternatively, the plurality of solid supports can be magnetic or paramagnetic microparticles or beads, capable of specifically binding to the analyte of interest or at least one reagent or conjugate. Additionally or alternatively, the sample processing component can further comprise the plurality of solid supports in at least one storage area. Additionally or alternatively, the sample processing component can further comprise at least one mixing area configured to mix the plurality of solid supports with the analyte of interest and at least one reagent or conjugate. Additionally or alternatively, the sample processing component can further comprise at least one reagent or conjugate in the at least one mixing area. Also, the at least one mixing area can have a volume capacity of about 25 μL or less.
[0011] Additionally or alternatively, the at least one reagent may be selected from the group consisting of a detectable label, a binding member, a dye, a surfactant, a diluent, and combinations thereof, and the binding member may comprise a receptor or an antibody.
[0012] Additionally or alternatively, the at least one wash area can be configured to wash away any molecules that are not bound to any solid support, and the at least one wash area has a volume capacity of about 10 μL or less.
[0013] Additionally or alternatively, the assay surface can include a plurality of channels, each of the plurality of channels being between the first sample preparation area and the second sample preparation area. Additionally or alternatively, the assay surface can include a plurality of stop elements, the assay surface can include a plurality of stop elements, at least one of the plurality of stop elements being between the first sample preparation area and the second sample preparation area. Additionally or alternatively, when the at least one stop area is removed, the body of liquid in the first area is fluidly connected with the body of liquid in the second area. Also, after passing through the at least one wash area, the plurality of solid supports are moved into the detection component under magnetic force.
[0014] Additionally or alternatively, the detection component can be configured for optical detection, analog detection, or digital detection. Additionally or alternatively, the detection component can include an array of elements, each of which is dimensioned to hold a single solid support of the plurality of solid supports. Additionally or alternatively, the array of elements can include an array of nanowells. Additionally or alternatively, the detection component can be further configured to receive a substrate fluid, the substrate fluid configured to provide a detectable signal from the plurality of solid supports, and the detection component can be further configured to receive an inert liquid, the inert liquid configured to seal each element of the array of elements that includes a portion of the substrate fluid and a single solid support of the plurality of solid supports. Additionally or alternatively, the detection component can be configured to acquire an image of the array of elements after the plurality of solid supports are moved into the detection component. Additionally or alternatively, the detection component can be configured for single molecule counting.
[0015] Additionally or alternatively, the assay surface comprises a hydrophobic material. Additionally or alternatively, the assay surface may further comprise a plurality of liquid bodies, a plurality of solid supports, and at least one reagent or conjugate in the plurality of sample preparation areas.
[0016] According to an aspect of the present disclosure, a method of analysis of an analyte of interest in a sample using an assay surface may include loading at least one body of liquid into at least one wash area of the assay surface, loading at least one body of liquid into a detection force zone, loading the body of liquid containing the analyte into the sample processing component, and detecting the analyte of interest in the detection component, the assay surface including a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, the detection component configured to receive the plurality of solid supports by magnetic force and to detect the presence of the analyte or determine the level or concentration of the analyte. The assay surface used may include any of the assay surfaces disclosed herein.
[0017] Additionally or alternatively, where the sample processing component comprises a plurality of solid supports, the method may further comprise moving the plurality of solid supports under magnetic force through a plurality of sample preparation regions into the detection component prior to detection of the analyte of interest in the detection component.
[0018] Additionally or alternatively, the method further includes loading a plurality of solid supports onto a sample processing component and moving the plurality of solid supports under magnetic force through a plurality of sample preparation regions into the detection component prior to detecting the analyte of interest in the detection component.
[0019] According to another aspect of the present disclosure, disclosed herein is an assay processing unit (APU) for performing sample processing and analyte detection on an assay surface including a sample processing component and a detection component. The APU can include an assay surface receiving component configured to receive and hold the assay surface, a magnetic element configured to generate a magnetic field, the magnetic field being movable along the assay surface when the assay surface is received by the receiving component, and one or more processors configured to move the magnetic field to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using the magnetic field.
[0020] Additionally or alternatively, the magnetic element may be a magnet. Additionally or alternatively, the APU may include a sliding element, e.g., a motor, configured to move the magnetic element under the control of one or more processors along a horizontal direction of a plane defined by a top surface of the assay surface when the assay surface is received by the receiving component. Additionally or alternatively, the APU may include a driving element, e.g., a motor or a string, configured to move the magnetic element vertically relative to a plane defined by a top surface of the assay surface under the control of the processor when the assay surface is received by the receiving component. Additionally or alternatively, the magnetic element may include an electromagnet configured to generate a moving magnetic field. Additionally or alternatively, the APU may include a mixing kinetics element, e.g., a vibration motor or an electromagnet controlled by one or more processors configured to mix at least one liquid body in at least one region of the assay surface under a predetermined frequency when the assay surface is received by the receiving component. Additionally or alternatively, the one or more processors may cause a detection component of the assay surface to acquire an image of the detection component when the assay surface is received by the receiving component.
[0021] According to an aspect of the present disclosure, a method of using an APU to perform sample processing and analyte detection on an assay surface including a sample processing component and a detection component can include accepting the assay surface within an assay surface accepting component of the APU, generating a magnetic field movable along the assay surface by a magnetic element of the APU, and detecting the analyte of interest in a detection component controlled by one or more processors of the APU.
[0022] Additionally or alternatively, where the assay surface comprises a plurality of solid supports, the method may further comprise moving a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using a magnetic field, prior to detection of the analyte of interest in the detection component.
[0023] Additionally or alternatively, the method may further include loading a plurality of solid supports into the sample processing component, and moving a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using a magnetic field prior to detection of an analyte of interest in the detection component. This method may be used with any assay surface or APU disclosed herein.
[0024] According to another aspect of the present disclosure, an assay processing system (APS) for analyzing an analyte of interest in a sample is disclosed. The APS can include one or more assay surfaces, at least one of which includes a sample processing component configured to process a sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a liquid body and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, and a detection component configured to accept the plurality of solid supports by magnetic force and detect the presence of an analyte or determine the level or concentration of the analyte, the APS can further include an assay processing unit (APU), the APU including an assay surface accepting component configured to accept and hold the one or more assay surfaces, a magnetic element configured to generate a magnetic field, the magnetic field being movable along the at least one assay surface when the at least one assay surface is accepted by the accepting component, and one or more processors configured to move the magnetic field to urge at least one solid support disposed on the at least one assay surface through the at least one liquid body in the at least one area of the sample processing component to the detection component of the assay surface using the magnetic field.
[0025] Additionally or alternatively, the APS can include any suitable assay surface according to the presently disclosed subject matter. Additionally or alternatively, the APS can include any suitable APU according to the presently disclosed subject matter.
[0026] According to an aspect of the present disclosure, a method of analysis of an analyte of interest in a sample using an assay processing system (APS) including an assay surface and an assay processing unit (APU) includes an assay surface including a sample processing component configured to process the sample for detection and a detection component, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a liquid body and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, the detection component configured to receive the plurality of solid supports by magnetic force and to detect the presence of an analyte or determine a level or concentration of the analyte, the method comprising: loading at least one liquid body into at least one wash area of the assay surface; loading at least one liquid body into the detection component; loading the liquid body including the analyte into the sample processing component; receiving the assay surface into an assay surface receiving component of the APU; generating a magnetic field by a magnetic element of the APU that is movable along the assay surface; and detecting the analyte of interest at the detection component controlled by one or more processors of the APU. Additionally or alternatively, one or more assay surfaces used in the method may comprise an assay surface according to the presently disclosed subject matter. Additionally or alternatively, an APU used in the method of the present disclosure may comprise an APU according to the presently disclosed subject matter.
[0027] Additionally or alternatively, where the at least one assay surface comprises a plurality of solid supports, the method further comprises, prior to detection of the analyte, moving a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to a detection component of the assay surface using a magnetic field.
[0028] Additionally or alternatively, the method may further include loading a plurality of solid supports onto the assay surface, and, prior to detection of the analyte, moving a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component using a magnetic field to a detection component of the assay surface.
[0029] According to another aspect of the present disclosure, a laboratory system for analysis of one or more analytes of interest in a plurality of samples is disclosed. The laboratory system may include one or more assay processing systems (APS), at least one APS including one or more assay surfaces, the at least one assay surface including a sample processing component configured to process a sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a liquid body and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, and a detection component configured to receive the plurality of solid supports by magnetic force and to detect the presence of an analyte or determine a level or concentration of the analyte, the laboratory system further including an assay processing unit (APU), the APU configured to receive and hold the one or more assay surfaces. the assay surface receiving component configured to receive the at least one assay surface; a magnetic element configured to generate a magnetic field, the magnetic field being movable along the at least one assay surface when the at least one assay surface is received by the receiving component; one or more processors configured to move the magnetic field to urge at least one solid support disposed on the at least one assay surface through at least one liquid body in at least one region of the sample processing component and to a detection component of the assay surface using the magnetic field; and a controller configured to control a plurality of the one or more APS to process a corresponding sample and to detect the presence of at least one corresponding analyte or determine the level or concentration of at least one corresponding analyte substantially in parallel.
[0030] Additionally or alternatively, the one or more APSs may comprise an APS according to the presently disclosed subject matter. The one or more assay surfaces may comprise any assay surface as disclosed herein. Additionally or alternatively, the APUs may comprise any APUs as disclosed herein.
[0031] Additionally or alternatively, the laboratory system is configured to perform one or more of an HIV p24 assay, an HBsAg assay, a Troponin I assay, a TSH assay, a Myoglobin assay, a PSA assay, a BNP assay, a PIVKA-II assay, an HIV Ab assay, an Estradiol assay, and a COVID-Ag assay. Additionally or alternatively, the laboratory system has a throughput of at least 360 samples per hour. Additionally or alternatively, the laboratory system has a throughput of at least 375 samples per hour per square meter of footprint of the laboratory system.
[0032] According to an aspect of the disclosure, a method of using a laboratory system includes an assay surface including a sample processing component configured to process a sample for detection and a detection component, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under magnetic force, and the detection component configured to receive the plurality of solid supports by magnetic force and detect the presence of an analyte or determine a level or concentration of the analyte, the method comprising: loading at least one body of liquid into at least one wash area of the assay surface; The method may include loading at least one body of liquid into a detection component, loading a body of liquid containing an analyte into a sample processing component, receiving an assay surface into an assay surface receiving component of the APU, generating a magnetic field movable along the at least one assay surface by a magnetic element of the APU, and detecting the analyte of interest in a detection component controlled by one or more processors of a corresponding APU, wherein the controller is configured to control multiple APSs of the one or more APSs to perform corresponding steps for corresponding samples and to detect the presence of at least one corresponding analyte or determine the level or concentration of at least one corresponding analyte in parallel.
[0033] Additionally or alternatively, where the at least one assay surface comprises a plurality of solid supports, the method may further comprise translating a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to a detection component of the assay surface using a magnetic field.
[0034] Additionally or alternatively, the method may further include loading a plurality of solid supports onto the at least one assay surface, and, prior to detection of the analyte, moving a magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface, using a magnetic field, through at least one liquid body in at least one region of the sample processing component and to a detection component of the assay surface.
[0035] Additionally or alternatively, the method may use an assay surface or APU according to the subject matter of the present disclosure. Additionally or alternatively, the method may perform one or more of an HIV p24 assay, an HBsAg assay, a Troponin I assay, a TSH assay, a Myoglobin assay, a PSA assay, a BNP assay, a PIVKA-II assay, an HIV Ab assay, an Estradiol assay, and a COVID-Ag assay. Additionally or alternatively, the method may be used on a laboratory system having a throughput of at least 360 samples per hour. Additionally or alternatively, the method may be used on a laboratory system having a throughput of at least 375 samples per hour per square meter footprint of the laboratory system.
[0036] According to another aspect of the present disclosure, a laboratory system for high throughput analysis of an analyte of interest in a sample includes a sample processing component configured to process the sample for detection, the sample processing component configured to obtain a level or concentration of the analyte in the sample, or a level or concentration of a conjugate indicative of the analyte in the sample, suitable for detection, and a detection component configured to detect the presence of the analyte in the sample. The laboratory system may have a time to result of less than 6 minutes, or a time to result in a range of 3 to 5 minutes, or a time to result in a range of 3 to 7 minutes. Additionally or alternatively, the laboratory system may have a throughput of at least about 360 samples per hour. Additionally or as a further alternative, the laboratory system may have a throughput of at least 375 samples per hour per square meter of the laboratory system, or in a range of 375 to 600 samples per hour per square meter of footprint of the laboratory system.
[0037] Also provided is a method for high throughput analysis of an analyte of interest in a sample. Such a method includes processing the sample for detection, including obtaining a level or concentration of the analyte in the sample or a level or concentration of a conjugate indicative of the analyte in the sample suitable for detection, and detecting the presence of the analyte in the sample. Processing the sample and detecting the presence of the analyte in the sample is completed in less than 6 minutes, or in the range of 3 to 5 minutes, or in the range of 3 to 7 minutes for the sample. Additionally or alternatively, processing the sample and detecting the presence of the analyte in the sample is completed at least about 360 samples per hour. Additionally or as a further alternative, processing the sample and detecting the presence of the analyte in the sample is completed at least about 375 samples per hour per square meter of laboratory system, or in the range of 375 to 600 samples per hour per square meter of laboratory system footprint. [Brief description of the drawings]
[0038] [Figure 1] FIG. 1 illustrates an exemplary assay surface for sample analysis including a sample processing component and a detection component in accordance with the presently disclosed subject matter. [Diagram 2] 1 illustrates an example embodiment of a detection component in accordance with the subject matter of this disclosure. [Diagram 3] 1 is a chart illustrating example noise level performance of analog and digital detection systems for purposes of comparison and validation of the presently disclosed subject matter. [Figure 4] 1 is a chart showing exemplary sensitivity characteristics of an exemplary assay surface having a digital detection component in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 5A] 1 is a chart showing exemplary sensitivity characteristics of an exemplary assay surface having a digital detection component in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 5B] 1 is a chart showing exemplary sensitivity characteristics of an exemplary assay surface having a digital detection component in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 5C] 1 is a chart showing exemplary sensitivity characteristics of an exemplary assay surface having a digital detection component in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 5D] 1 is a chart showing exemplary sensitivity characteristics of an exemplary assay surface having a digital detection component in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 6-1] 1 is a chart showing additional data regarding exemplary sensitivity performance using an exemplary assay surface having a digital detection component for sample analysis according to the presently disclosed subject matter to perform an HIV p24 assay compared to a system using analog detection. [Figure 6-2]1 is a chart showing additional data regarding exemplary sensitivity performance using an exemplary assay surface having a digital detection component for sample analysis according to the presently disclosed subject matter to perform an HIV p24 assay compared to a system using analog detection. [Figure 6-3] 1 is a chart showing additional data regarding exemplary sensitivity performance using an exemplary assay surface having a digital detection component for sample analysis according to the presently disclosed subject matter to perform an HIV p24 assay compared to a system using analog detection. [Figure 7A] 1 is a chart showing exemplary sensitivity and dynamic range characteristics of an exemplary assay surface having digital detection components for sample analysis in accordance with the presently disclosed subject matter to perform an estradiol assay as compared to a system using analog detection. [Figure 7B] 1 is a chart showing exemplary sensitivity and dynamic range characteristics of an exemplary assay surface having digital detection components for sample analysis in accordance with the presently disclosed subject matter to perform an estradiol assay as compared to a system using analog detection. [Figure 7C] 1 is a chart showing exemplary sensitivity and dynamic range characteristics of an exemplary assay surface having digital detection components for sample analysis in accordance with the presently disclosed subject matter to perform an estradiol assay as compared to a system using analog detection. [Figure 8-1] 1 is a chart illustrating exemplary sensitivity and processing time characteristics of an exemplary assay surface having digital detection components in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 8-2] 1 is a chart illustrating exemplary sensitivity and processing time characteristics of an exemplary assay surface having digital detection components in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 9]1 is a chart showing intensity characteristics during an enzymatic reaction using an exemplary assay surface for sample analysis according to the presently disclosed subject matter. [Figure 10] 1A-1D illustrate exemplary detection techniques of assay surfaces for sample analysis in accordance with the presently disclosed subject matter. [Figure 11A] 1 is a chart illustrating exemplary dynamic range characteristics of an exemplary assay surface for sample analysis using digital detection in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 11B] 1 is a chart illustrating exemplary dynamic range characteristics of an exemplary assay surface for sample analysis using digital detection in accordance with the presently disclosed subject matter compared to a system using analog detection. [Figure 12] FIG. 2 illustrates, in top view, an exemplary assay surface for use with an assay processing unit (APU) for sample analysis in accordance with the presently disclosed subject matter. [Figure 13] 1 illustrates the movement of microparticles or beads through a body of liquid using a moving magnetic field in an exemplary assay surface in accordance with the presently disclosed subject matter. [Figure 14] 1 is an image showing another embodiment of an assay surface for use with an assay processing unit (APU), assay processing system (APS) or laboratory system for sample analysis in accordance with the subject matter of the present disclosure. [Figure 15] FIG. 1 illustrates another embodiment of an assay surface for use with an APU, APS, or laboratory system for sample analysis in accordance with the presently disclosed subject matter. [Figure 16A] 1 is a chart detailing an exemplary washing process for an assay surface for purposes of comparison with a system using conventional sample preparation components. [Figure 16B] 1 is a chart detailing an exemplary washing process for an assay surface for purposes of comparison with a system using conventional sample preparation components. [Figure 17]1 is a chart illustrating the properties of an exemplary assay surface for sample analysis according to the presently disclosed subject matter compared to conventional systems for sample analysis. [Figure 18] 1 is a chart showing details of an exemplary laboratory system using one or more assay surfaces for sample analysis in accordance with the presently disclosed subject matter as compared to conventional systems for sample analysis. [Figure 19] FIG. 2 illustrates additional details of an example APU of an example laboratory system for sample analysis in accordance with the presently disclosed subject matter. [Figure 20] FIG. 1 illustrates another embodiment of an assay surface for sample analysis in accordance with the presently disclosed subject matter. [Figure 21] FIG. 1 shows an exploded view of an exemplary assay processing system (APS) having an APU and an exemplary assay surface for sample preparation and detection. [Figure 22] FIG. 22 shows a side view of an exemplary APS for sample preparation and detection of FIG. 21. [Figure 23A] FIG. 22 illustrates an exemplary washing technique in a washing region of an exemplary assay surface using the exemplary APS of FIG. 21. [Figure 23B] FIG. 22 illustrates an exemplary washing technique in a washing region of an exemplary assay surface using the exemplary APS of FIG. 21. [Figure 24A] FIG. 13 shows the assembly of another embodiment of an assay surface comprising multiple stopping elements. [Figure 24B] FIG. 13 shows the assembly of another embodiment of an assay surface comprising multiple stopping elements. [Figure 24C] FIG. 13 shows the assembly of another embodiment of an assay surface comprising multiple stopping elements. [Figure 24D] FIG. 13 shows the assembly of another embodiment of an assay surface comprising multiple stopping elements. [Diagram 25] FIG. 13 shows another embodiment of an assay surface comprising multiple stopping elements. [Figure 26]22 is a chart showing the washing efficiency of an HIV Ag p24 assay using an exemplary washing technique in the exemplary APS of FIG. 21 in accordance with the presently disclosed subject matter compared to the King-Fisher washing technique. [Figure 27A] 1A-1C show exemplary bead loading techniques for loading beads or microparticles into exemplary detection regions of an assay surface in accordance with the presently disclosed subject matter. [Figure 27B] 1A-1C show exemplary bead loading techniques for loading beads or microparticles into exemplary detection regions of an assay surface in accordance with the presently disclosed subject matter. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0039] Reference will now be made in detail to various exemplary embodiments of the presently disclosed subject matter, example embodiments of which are illustrated in the accompanying drawings. The structure and corresponding method of operation of the presently disclosed subject matter will be described in conjunction with a detailed system description.
[0040] The systems and methods described herein can be used for detection of an analyte of interest in a sample, including, but not limited to, a sample for analysis in a laboratory environment. By way of example and not limitation, the sample can include a bodily fluid sample, such as, in one embodiment, a blood, plasma, serum, saliva, sweat, urine sample, or any other sample suitable for analysis using the systems and techniques described herein. In one embodiment, the systems and techniques for sample analysis described herein can analyze a single sample in about 5 minutes or less. Additionally or alternatively, in one embodiment, the systems and techniques for sample analysis described herein can have a throughput of at least about 360 samples per hour, more preferably at least about 375 samples per square meter per hour, or in the range of about 375-600 samples per square meter per hour.
[0041] According to an aspect of the subject matter of the present disclosure, an exemplary sample analysis system is provided along with an exemplary method of sample analysis. The exemplary sample analysis system and method can use an exemplary assay surface, an assay processing unit (APU), an assay processing system (APS), and a laboratory system for sample processing and detection. For example, in one embodiment, the exemplary sample analysis system and method can be used to perform any type of assay, such as a sandwich immunoassay (e.g., a monoclonal-polyclonal sandwich immunoassay), including, but not limited to, enzyme-based detection (e.g., enzyme immunoassay (EIA) or enzyme-linked immunosorbent assay (ELISA)), competitive inhibition immunoassay (e.g., forward and reverse), enzyme multiplied immunoassay technique (EMIT), competitive binding assay, bioluminescence resonance energy transfer (BRET)), one-step antibody detection assay, homogeneous assay, heterogeneous assay, capture-on-the-fly assay, or any other immunoassay.
[0042] By way of example and not limitation, in one embodiment, a detectable label, such as one or more fluorescent labels or tags, can be attached to the analyte for detection. Additionally or alternatively, one or more labels or tags can be attached to the detection antibody, for example, attached by a cleavable linker that is chemically or photocleavable.
[0043] By way of example and not by way of limitation, "beads," "particles," and "microparticles" are used interchangeably herein to refer to approximately spherical solid supports. "Magnetic beads" and "paramagnetic beads" refer to approximately spherical solid supports that can be accelerated under magnetic forces. By way of example and not by way of limitation, "chips," "reaction chips," and "sample chips" are used interchangeably herein to refer to assay surfaces for the analysis of an analyte of interest in a sample according to the subject matter of the present disclosure.
[0044] FIG. 1 illustrates an exemplary sample assay surface (100) according to the subject matter of the present disclosure. As disclosed herein, an exemplary system for sample analysis broadly includes two components: a sample processing component (110) and a detection component (120). The sample processing component (110) can be configured to prepare the sample for analysis and / or detection, which may include, for example, but not limited to, purifying the sample of interest, isolating an analyte of interest in the sample, and / or combining the sample with a reactive element, such as a conjugate, enzyme, reagent, diluent, microparticle, or other element used to perform the analysis and / or detection of interest. By way of example and not limitation, the sample processing component (110) can be configured to process the analyte of interest in the sample, or a detectable component of the sample, such as a conjugate, to a level or concentration suitable for detection by the assay surface (100). The detection component (120) can be configured to detect or analyze the analyte of interest in the sample. Although the exemplary sample analysis system is described herein using optical-based detection components, any suitable detection components may be used, such as, but not limited to, electrical detection, electrochemical detection, viscoelastic detection, or any other suitable detection technology. If optical detection is used, such optical detection may use, by way of example and not limitation, digital detection techniques, analog detection techniques, or a combination of digital and analog detection techniques.
[0045] In one embodiment, the sample processing component (110) can be configured to prepare the sample using any suitable sample preparation technique. By way of example and not limitation, the sample preparation component can be configured to separate and / or purify an analyte of interest in a sample. For example and not limitation, the sample preparation component can include manual pipetting, including but not limited to using one or more pipettes to move the sample to a reaction site, mix one or more reactive elements with the sample, and / or wash the sample. Additionally or alternatively, an automated pipetting system can be used to perform any or all sample preparation by the sample preparation component. Additionally or as a further alternative, in one embodiment, the sample preparation component can be configured to perform a sample preparation process step, by way of example and not limitation, in which particles or beads are passed through a liquid surface and / or through an air-water or oil-water boundary.
[0046] By way of example and not limitation, in one embodiment, a heterogeneous format can be used. For example, after a test sample is obtained from a subject, a first mixture can be prepared. In one embodiment, the mixture can include the test sample to be evaluated for an analyte of interest and a first specific binding partner. The first specific binding partner and any analyte of interest in the test sample can be combined to form a first specific binding partner-analyte of interest complex. In one embodiment, the first specific binding partner can be an anti-analyte of interest antibody or a fragment thereof. The order in which the test sample and the first specific binding partner are added to form the mixture can be reversed. In one embodiment, the first specific binding partner can be immobilized on a solid phase. The solid phase used in the immunoassay (e.g., of the first specific binding partner and optionally the second specific binding partner) can be any solid phase, such as, but not limited to, magnetic particles, beads, nanobeads, microbeads, nanoparticles, microparticles, membranes, scaffolding molecules, films, filter paper, discs, or chips (e.g., microfluidic chips).
[0047] By way of example and not by way of limitation, in one embodiment, sample processing may include incubating the sample with the first binding member, e.g., after mixing, for a suitable period of time to allow binding interactions between the binding member and the analyte to occur. In one embodiment, incubation may be performed in a binding buffer that promotes specific binding interactions. For example and not by way of limitation, by altering the binding buffer, the binding affinity and / or specificity of the first binding member and / or second binding member may be manipulated or altered in the assay. For example, in one embodiment, binding affinity and / or specificity may be increased or decreased by altering the binding buffer.
[0048] After a mixture containing the first specific binding partner-analyte of interest complex is formed, including before or after incubation (if performed), any unbound analyte of interest can be removed from the complex using any suitable technique. For example, but not by way of limitation, unbound analyte of interest can be removed by washing. By way of example and not by way of limitation, in one embodiment, the disclosed systems and methods can perform a one-step or two-step assay preparation. In one embodiment, the first specific binding partner can be present in excess of any analyte of interest present in the test sample such that all analytes of interest present in the test sample can be bound by the first specific binding partner.
[0049] After the unbound analyte of interest is removed, by way of example, in one embodiment, a second specific binding partner can be added to the mixture to form a first specific binding partner-analyte of interest-second specific binding partner complex. The second specific binding partner can be an anti-analyte of interest (such as an antibody) that binds to an epitope on the analyte of interest that is different from the epitope on the analyte of interest bound by the first specific binding partner. Additionally or alternatively, the second specific binding partner can be labeled with or contain a detectable label (e.g., a fluorescent label, a tag attached by a cleavable linker, or any other suitable label).
[0050] Alternatively or alternatively, in one embodiment the immunoassay may incorporate an immobilized antibody or fragment thereof. The antibody may be immobilized on any suitable support, such as, but not limited to, a magnetic or chromatographic matrix particle, a latex particle or a surface modified latex particle, a polymer or polymer film, a plastic or plastic film, a planar substrate, a microfluidic surface or a piece of solid substrate material.
[0051] Sample processing may include additional or alternative steps to obtain a level or concentration of an analyte or conjugate, such as an amplification component, suitable for detection. For example, but not limited to, amplification or degradation may be performed, such as when the assay involves molecular processes. By way of example and not limitation, amplification may be performed using any suitable amplification technique, including isothermal amplification and polymerase chain reaction (PCR) amplification. By way of example only and not limitation, amplification may be performed using transcription mediated amplification (TMA), recombinase polymerase amplification (RPA), or any suitable isothermal amplification technique.
[0052] Additionally or alternatively, in one embodiment, the detection component (120) can be configured to detect or analyze an analyte of interest in a sample, including, but not limited to, detecting the presence or absence of the analyte and / or determining the concentration of the analyte in the sample. By way of example and not limitation, the detection component can be performed using optical detection, which can include analog detection, digital detection, illumination detection, fluorescence detection, or any combination of these techniques. Additionally or alternatively, the detection component can be configured to perform single molecule counting.
[0053] The sensitivity of the detection component may affect other characteristics of the sample analysis system that affect the overall performance of the system, as described further herein. As used herein, the "sensitivity" of the detection component refers to the level or concentration of the analyte of interest (or conjugate, if used) in a sample that is detectable by the detection component (120), where a lower detectable level or concentration indicates a higher sensitivity. For example, but not by way of limitation, an increased sensitivity of the detection component (120) may allow for the detection of lower concentrations of the analyte in a sample, thereby reducing the time involved in processing the analyte of interest to obtain a concentration of the analyte (or conjugate, if used) suitable for detection, as compared to conventional systems.
[0054] Additionally or alternatively, increased sensitivity of the detection component may allow detection to be performed using less sample volume, less reagent or conjugate material, less particles or beads, or any combination thereof, to obtain an analyte concentration suitable for detection in a similar or faster time compared to conventional systems. By way of example and not limitation, the reagent may be selected from the group consisting of detectable labels, binding members, dyes, surfactants, diluents, and combinations thereof. When a binding member is used, the binding member may be a receptor or an antibody. In this way, sample preparation time may be improved due at least in part to the increased reaction rate that can be achieved using less involved sample manipulation and / or less sample volume, less reagent or conjugate material, and / or less particles or beads to obtain an analyte concentration suitable for detection. Thus, detection components with increased sensitivity may be used to reduce the time to perform an assay, the cost of materials used in the assay, and / or the amount of sample material (e.g., bodily fluid or organic matter) taken to perform the assay.
[0055] For purposes of illustration only, and not limitation, further details of systems and methods for sample analysis in accordance with the subject matter of the present disclosure, including exemplary sample processing and detection components, are described in U.S. Patent Application Publication Nos. 2018 / 0095067, 2018 / 0104694, and 2018 / 0188230, each of which is incorporated by reference in its entirety herein.
[0056] FIG. 2 illustrates an exemplary detection component 120 according to the subject matter of the present disclosure. Referring to FIG. 2, by way of example and not limitation, an exemplary digital detection component (200) is illustrated. In one embodiment, sample processing is performed at (201) to obtain a concentration of analyte (or conjugate, if used) suitable for detection prior to entering the digital detection component (200). Sample processing can include any combination of steps described herein. For example, a support medium, including but not limited to, microparticles, beads, or other labels, can be mixed with the sample. In one embodiment, reagents including antibodies and coated microparticles can be combined. The solution can be washed, for example, to remove excess reagents and / or unbound microparticles. Any suitable number of washes can be performed for each wash step, including one, two, three, or more washes, each wash can be performed in a single chamber or location or in different chambers or locations. For example, but not limited to, in one embodiment, three washes can be performed. A conjugate can be added to bind to the analyte of interest in the sample. For example, but not by way of limitation, the conjugate may include one or more reagents or enzymes selected or configured to react with the analyte of interest to generate a signal for detection by the detection component. The solution to which the conjugate is added may be washed, for example, to remove excess conjugate that is not bound to the analyte of interest. Any suitable number of washes, including one, two, three or more, may be performed for each wash step, and each wash may be performed in a single chamber or location or in a different chamber or location. For example, but not by way of limitation, in one embodiment, three washes may be performed. The microparticles bound to the analyte and the conjugate may be added to the substrate for detection. By way of example and not by way of limitation, the substrate may include a detection region. The microparticles may be added to the substrate using any suitable technique, including, but not limited to, pipetting, magnetic force, or dielectrophoresis. In one embodiment, the detection region may include one or more nanowells.
[0057] At (200), digital detection is performed. For example, in one embodiment, at (202), microparticles can be transferred to a detection area, for example, in one embodiment, an array of nanowells. The microparticles can be transferred to the nanowells using any suitable technique, including, but not limited to, pipetting, magnetic forces, or dielectrophoresis. At (203), a hydrophobic liquid, for example, an oil, can be added to seal the nanowells, particularly to prevent migration of beads or evaporation of aqueous fluids in the nanowells. By way of example only, the oil added can be mineral oil or other types of suitable oils. Additionally or alternatively, other suitable hydrophobic liquids can be added to seal the nanowells. Additionally or alternatively, dyes or contrast agents can be added to enhance contrast or otherwise improve optical conditions for detection of analytes of interest in the nanowells. Methods of using dyes in signal generating digital assays are disclosed, for example, but not limited to, in International Patent Application Publication No. WO 2018 / 143478, which is incorporated herein by reference in its entirety. At 204, one or more images of the microparticles are taken and analyzed to determine the presence or absence of an analyte of interest in the sample and / or the concentration of the analyte of interest.
[0058] Digital detection components and methods can significantly increase the detection sensitivity in systems for sample analysis compared to systems using analog detection. Thus, detection can be performed using lower concentrations of analyte, thereby allowing for a reduction in the time to process the sample for detection. Additionally or alternatively, detection can be performed using smaller sample volumes, smaller amounts of reagent material, smaller amounts of conjugate material, smaller amounts of microparticles, or any combination thereof, thereby reducing the cost of performing each assay. Thus, as described herein, sample preparation time can be improved due at least in part to the increased reaction rates that can be achieved using less involved sample manipulations (e.g., faster wash times) and / or smaller amounts of sample volumes, smaller amounts of reagent or conjugate material, and / or smaller amounts of particles or beads to obtain an analyte concentration suitable for detection. As further described herein, assays can be performed using smaller sample volumes and / or reagent material using smaller equipment that can reduce the footprint of the laboratory system for performing the assay. Additionally or alternatively, the increased detection sensitivity can provide additional benefits when used in conjunction with multiplexing. For example, but not by way of limitation, when multiple analytes and corresponding signals are combined into a single multiplexed assay, the noise level associated with the detection of each analyte signal can multiply into the total noise level of the multiplexed system. By increasing the detection sensitivity of each signal that is detected, the increased sensitivity can be multiplied to further reduce the total noise level of the multiplexed system.
[0059] Digital detection can provide increased sensitivity, for example, due at least in part to reduced noise in detection relative to the signal being measured, thereby achieving a higher signal-to-noise ratio. FIG. 3 is a chart showing the detection noise level of an exemplary digital detection system of the presently disclosed subject matter compared to a sample analysis system using analog detection (e.g., the Abbott ARCHITECT™ line of systems), for purposes of illustrating and validating the presently disclosed subject matter. By way of example only and not by way of limitation, the assay shown in FIG. 3 was performed as follows: For the ARCHITECT™ HIV Ag / Ab Combo assay (p24 assay) on the ARCHITECT™, 100 μL of negative sample (as the "0" concentration sample) was applied to the first 18-minute immune reaction and the second 4-minute immune reaction. By way of example and not by way of limitation, a wash process may require additional time. For example, in one embodiment, the first immune reaction can be used to analyze molecules using microparticles, and the second immune reaction can be used to detect antigens with a second antibody. The number of conjugated molecules was calculated from the chemiluminescence relative light unit (RLU) value. For digital HIV p24, 100 μL of negative sample (as "0" concentration sample) was applied to a total of 18 min immunotime assay. The number of conjugated molecules was calculated by counting the digital signal.
[0060] For the ARCHITECT™ HBsAg assay, 75 μL of the negative sample (as the "0" concentration sample) was applied to the immunoreaction time assay for a total of 22 minutes (18 minutes of immunoreaction and 4 minutes of enzyme reaction). The number of conjugated molecules was calculated from the relative light unit (RLU) value of the chemiluminescence. For the digital HBsAg assay, 75 μL of the negative sample (as the "0" concentration sample) was applied to the immunoreaction time assay for a total of 18 minutes. The number of conjugated molecules was calculated by counting the digital signal.
[0061] For the ARCHITECT™ troponin assay, 150 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 8 minutes (4 minutes of immunoreaction and 4 minutes of enzymatic reaction). By way of example and not limitation, the washing process may require additional time. The number of conjugate molecules was calculated from the chemiluminescence relative light unit (RLU) value. For the digital troponin I assay, 100 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 8 minutes. The number of conjugate molecules was calculated by counting the digital signal.
[0062] For the ARCHITECT™ TSH assay, 150 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 22 minutes (18 minutes of immunoreaction and 4 minutes of enzyme reaction). By way of example and not limitation, the washing process may require additional time. The number of conjugate molecules was calculated from the chemiluminescence relative light unit (RLU) value. For the digital TSH assay, 110 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 18 minutes. The number of conjugate molecules was calculated by counting the digital signal.
[0063] For the ARCHITECT™ myoglobin assay, 20 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 8 minutes (4 minutes of immunoreaction and 4 minutes of enzyme reaction). By way of example and not limitation, the washing process may require additional time. The number of conjugate molecules was calculated from the chemiluminescence relative light unit (RLU) value. For the digital myoglobin assay, 20 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 8 minutes. The number of conjugate molecules was calculated by counting the digital signal.
[0064] For the ARCHITECT™ PSA assay, 50 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 22 minutes (18 minutes of immunoreaction and 4 minutes of enzyme reaction). By way of example and not limitation, the washing process may require additional time. The number of conjugate molecules was calculated from the chemiluminescence relative light unit (RLU) value. For the digital PSA assay, 50 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 18 minutes. The number of conjugate molecules was calculated by counting the digital signal.
[0065] For the ARCHITECT™ PIVKA-II assay, 30 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 22 minutes (18 minutes of immunoreaction and 4 minutes of enzyme reaction). By way of example and not limitation, additional time may be required for the washing process. The number of conjugate molecules was calculated from the relative light unit (RLU) value of chemiluminescence. For the digital PIVKA-II assay, 30 μL of negative sample (as the “0” concentration sample) was applied to the immunoreaction time assay for a total of 26 minutes. For example, in one embodiment, during the 26 minutes of immunoreaction time, 18 minutes may be involved in the first reaction and 8 minutes in the second reaction to reduce the variation in the assay process. The number of conjugate molecules was calculated by counting the digital signal.
[0066] With further reference to FIG. 3, the noise level of detection correlates with the number of conjugate molecules. On the left side of the chart, for assays performed by a sample analysis system using analog detection, including HIV p24, HBsAg, troponin I, TSH, myoglobin, PSA, BNP, and PIVKA-II, the noise level is greater than about 79,000 noise conjugate molecules, about 7,900 to 560,000 noise conjugate molecules. On the right side of the chart, for assays performed by a sample analysis system using digital detection, the noise level is less than about 1800 noise conjugate molecules, about 300 to 1800 noise conjugate molecules. Thus, a sample analysis system using digital detection can have a noise reduction of greater than 99% compared to a sample analysis system using analog detection.
[0067] 4 illustrates the sensitivity improvement of a sample analysis system using digital detection compared to a sample analysis system using analog detection. By way of example and not limitation, in assays for HBsAg, HIV p24, myoglobin, PSA and HIV Ab, the sample analysis system using digital detection has a sensitivity improvement of over 100-fold compared to a sample analysis system using analog detection. In assays for Troponin I and TSH, the sample analysis system using digital detection has a sensitivity improvement of over 10-fold compared to a sample analysis system using analog detection. In an assay for PIVKA-II, the sample analysis system using digital detection has a sensitivity improvement of about 5-fold compared to a sample analysis system using analog detection.
[0068] The above data reveals that the features of digital detection can be utilized to improve the overall testing process. As described herein, digital detection can be performed using lower concentrations of analyte compared to analog detection, thereby allowing for a reduction in the time to process the sample to obtain a signal level or concentration suitable for detection. In one embodiment, the sample processing requires a reduced total incubation time, which can be performed in one step, for example and without limitation, or alternatively, can require two steps, including an immunoreaction time and an enzyme reaction time, resulting in a total incubation time. FIG. 5A illustrates the incubation times to achieve various signal-to-noise ratios (S / N) with an exemplary assay surface using digital detection compared to a sample analysis system using analog detection to perform an HBsAg assay. By way of example only and not by way of limitation, the incubation was performed as follows: Approximately 10 μL of sample was applied to the digital HBsAg assay. The X-axis indicates the immunoreaction time and the enzyme reaction time. Sensitivity (S / N) was calculated from the signal from the positive sample divided by the signal from the negative sample. The sample volume for the equivalent analog detection of the HBsAg assay was 75 μL. As shown in FIG. 5A, the assay surface using digital detection can perform the HBsAg assay using a single-step incubation with an incubation time of 3 minutes and achieve a signal-to-noise ratio of 3.2. In comparison, the sample analysis system using analog detection can perform the HBsAg assay using a two-step incubation with an immunoreaction time of 18 minutes and an enzyme reaction time of 4 minutes for a total incubation time of 22 minutes and achieve a signal-to-noise ratio of 1.8. Thus, the assay surface using digital detection can achieve approximately 75% increased sensitivity in approximately one-eighth (1 / 8) the time for incubation for the HBsAg assay compared to the sample analysis system using analog detection.
[0069] FIG. 5B illustrates the incubation times to achieve various signal to noise ratios with an exemplary assay surface using digital detection compared to a sample analysis system using analog detection to perform an HIV p24 assay. By way of example only and not by way of limitation, incubations were performed as follows: Approximately 10 μL of sample was applied to the digital HIV p24 assay. The X-axis indicates the immunoreaction time and the enzymatic reaction time. Sensitivity (S / N) was calculated from the signal from the positive sample divided by the signal from the negative sample. The sample volume for the equivalent analog detection of the HIV Ag / Ab combo assay was 100 μL. As shown in FIG. 5B, the assay surface using digital detection can perform an HIV p24 assay using a single-step incubation with a 3 minute incubation time to achieve a signal to noise ratio of 3.7. In comparison, a sample analysis system using analog detection can perform an HIV p24 assay using a two-step incubation with an 18 minute immunoreaction time and a 4 minute enzymatic reaction time for a total incubation time of 22 minutes to achieve a signal to noise ratio of 1.6. Thus, an assay surface using digital detection can achieve approximately 130% increased sensitivity in approximately one-eighth (1 / 8) the time for incubation for an HIV p24 assay compared to a sample analysis system using analog detection.
[0070] FIG. 5C illustrates the incubation times to achieve various S / N ratios with an assay surface using digital detection compared to a sample analysis system using analog detection to perform a PSA assay. By way of example only and not limitation, incubations were performed as follows: Approximately 10 μL of sample was applied to the digital total PSA assay. The X-axis shows the immunoreaction time and the enzymatic reaction time. Sensitivity (S / N) was calculated from the signal from the positive sample divided by the signal from the negative sample. The sample volume for the equivalent analog detection of the total PSA assay was 50 μL. As shown in FIG. 5C, the assay surface using digital detection can perform a PSA assay using a single-step incubation with an incubation time of 5 minutes to achieve an S / N ratio of 2.5. In comparison, a sample analysis system using analog detection can perform a PSA assay using a two-step incubation with an immunoreaction time of 18 minutes and an enzymatic reaction time of 4 minutes for a total incubation time of 22 minutes to achieve an S / N ratio of 1.5. Thus, an assay surface using digital detection can achieve approximately 67% increased sensitivity in approximately one-quarter (1 / 4) the time for incubation for a PSA assay compared to a sample analysis system using analog detection.
[0071] FIG. 5D illustrates the incubation times to achieve various S / N ratios with an assay surface using digital detection compared to a sample analysis system using analog detection to perform an HIV Ab assay. By way of example only and not limitation, incubations were performed as follows: Approximately 10 μL of sample was applied to the digital HIV Ab assay. The X-axis shows the immunoreaction time and the enzymatic reaction time. Sensitivity (S / N) was calculated from the signal from the positive sample divided by the signal from the negative sample. The sample volume for the equivalent analog detection of the HIV Ag / Ab combo assay was 100 μL. As shown in FIG. 5D, the assay surface using digital detection can perform an HIV Ab assay using a single-step incubation with a 5 minute incubation time to achieve a S / N ratio of 10.4. In comparison, the sample analysis system using analog detection can perform an HIV Ab assay using a two-step incubation with an 18 minute immunoreaction time and a 4 minute enzymatic reaction time for a total incubation time of 22 minutes to achieve a S / N ratio of 2.1. Thus, an assay surface using digital detection can achieve approximately 500% increased sensitivity in approximately one-quarter (1 / 4) the time for incubation for an HIV Ab assay compared to a sample analysis system using analog detection.
[0072] Figure 6 is a chart showing the improved sensitivity based on additional data obtained from seroconversion panel evaluation of HIV p24 assays with assay surfaces using digital detection compared to sample analysis systems using analog detection (e.g., Abbott m2000HIV, Roche HIV RNA CAP / CTM v.1.0, and Abbott HIV Ag / Ab ARCHITECT™ systems). As shown in Figure 6, the assay surfaces using digital detection have improved sensitivity compared to sample analysis systems using analog detection.
[0073] Digital detection can be configured to provide an expanded dynamic range of detection in addition to or as an alternative to improved sensitivity compared to a sample analysis system using analog detection. FIGS. 7A-7B show exemplary calibration curves for an estradiol assay with an exemplary assay surface using digital detection configured for high sensitivity and an assay surface using digital detection configured for high dynamic range compared to a sample analysis system using analog detection. As shown in FIG. 7A, the curve labeled "High Sensitivity" shows image analysis configured for high sensitivity with a threshold of 100 units of response intensity measured by the detector for digital detection of estradiol. As shown in FIGS. 7A-7B, the curve labeled "High Dynamic Range" shows image analysis configured for high dynamic range with a threshold of 25 units of response intensity measured by the detector for digital detection of estradiol. In comparison, in FIGS. 7A-7B, the curve labeled "ARCHITECT™" shows image analysis with a sample analysis system using analog detection (e.g., Abbott ARCHITECT™). As shown in Figure 7A, the high sensitivity digital configuration has a greater response at lower concentrations of estradiol compared to ARCHITECT™. As shown in Figures 7A-7B, the high dynamic range digital configuration has a greater response at higher concentrations of estradiol compared to ARCHITECT™. Thus, compared to a sample analysis system using analog detection, an assay surface using digital detection can be configured to have similar sensitivity with a higher dynamic range, or higher sensitivity with a similar dynamic range, or a combination of higher sensitivity and higher dynamic range.
[0074] FIG. 7C shows an exemplary calibration curve of a competitive assay of estradiol with an assay surface using digital detection compared to a sample analysis system using analog detection. The vertical axis shows the Cal C signal per noise (C / A ratio), which indicates the sensitivity for estradiol assay, where a lower C / A ratio indicates a higher sensitivity. As shown in FIG. 7C, after an incubation time of 2 minutes, the assay surface using digital detection has a C / A ratio of 0.45, which is lower than the sample analysis system using analog detection, which has a C / A ratio of 0.67.
[0075] For purposes of illustrating and validating the subject matter of the present disclosure, FIG. 8 shows data for various assays performed with an exemplary assay surface using digital detection compared to a sample analysis system using analog detection (e.g., Abbott ARCHITECT™). For example and without limitation, a TSH assay was performed. As shown in FIG. 8, the signal to noise ratio of the assay surface using digital detection is 28 times higher than the sample analysis system using analog detection for the TSH assay. The limit of detection (LOD) of the sample analysis system using digital detection is at least 22.9 times lower than the sample analysis system using analog detection for the TSH assay.
[0076] To obtain a similar limit of detection (LOD) with a similar signal-to-noise ratio, the assay surface using digital detection used a 4 minute incubation time compared to the sample analysis system using analog detection, which used a 22 minute incubation time. Thus, the digital detection system described herein allows for a significantly shorter sample processing time than the time required to achieve adequate results for analog detection. As shown in FIG. 8, compared to analog detection, for an otherwise comparable assay, the assay surface using digital detection has equal or higher sensitivity and shorter processing time compared to the sample analysis system using analog detection. For example, for the assays tested and measured shown in FIG. 8, the assay surface using digital detection improved detection sensitivity based on a signal-to-noise ratio of 11 to 189 times.
[0077] According to another aspect of the presently disclosed subject matter, assay surfaces using digital detection can be configured to have a wider dynamic range of detection in addition to or as an alternative to higher sensitivity compared to sample analysis systems using only analog detection: when the concentration of the analyte of interest in the sample exceeds a threshold value, the detection component becomes saturated where further increases in concentration do not produce a measurable change in the signal detectable by the detection component.
[0078] As a result of the configuration of the assay surface using digital detection to increase the dynamic range, various improvements in the assay can be obtained, including cost and time improvements. For example, various conditions of the assay can be modified to take advantage of the increased dynamic range. By way of example and not limitation, modifications made to the assay conditions can include reducing the amount of sample, increasing the concentration of substrate in the sample, decreasing the concentration of microparticles or conjugates in the sample, or any combination of such modifications or similar modifications.
[0079] Additionally or alternatively, the configuration of the sample analysis system can be modified to take advantage of the improved dynamic range. By way of example and not limitation, the sample analysis system can be modified to reduce the time of enzyme reaction prior to detection, or to use rates for more precise control of the enzyme reaction signal, or to use a combination of such modifications or similar modifications.
[0080] FIG. 9 shows the change in fluorescence intensity over enzyme reaction time for an exemplary assay. As shown in FIG. 9, during a high concentration assay, as the enzyme reaction increases, there may be only a small or no change in the detection signal, which may be due to saturation. Thus, if the detection of the sample occurs after a certain amount of incubation, the duration of which may vary depending on the type and conditions of the assay, the fluorescence signal will not show a measurable difference in intensity as the concentration increases, at which point the detection system can be considered saturated. Thus, by shortening the observation time in the sample analysis system, the difference in intensity can be measured for a wider concentration range in the extended dynamic range, and images can be taken at any one or more time points during the enzyme reaction time to obtain one or more intensities corresponding to the concentration of the analyte of interest in the sample.
[0081] FIG. 10 illustrates an exemplary modification made to an assay surface using digital detection to reduce observation time. By way of example and not limitation, an exemplary detection method (1000) is illustrated with reference to FIG. 10. At (1001), oil is added to the analyte solution to form nanochambers for detection. At (1002), black dye is added to the analyte solution to darken the background and increase contrast for optical detection. At (1003), an optical detection device (e.g., a CCD camera) is focused to resolve an image of the analyte solution, and at (1004), the optical detection device captures an image of the analyte solution for detection. The time to perform the detection method (1000) from oil addition (1001) to image capture (1004) is approximately 107 seconds.
[0082] Further referring to FIG. 10, by way of example and not limitation, an exemplary detection method (1010) according to the subject matter of the present disclosure is shown. At (1011), an optical detection device (e.g., a CCD camera) is focused to resolve an image of the analyte solution. At (1012), both the oil and the black solution are added to the analyte solution at once. At (1013), the optical detection device acquires an image of the analyte solution for detection. The time to perform the detection method (1010) is about 17 seconds, which is about one-sixth of the detection method (1000). As described herein, the dynamic range can be increased by shortening the observation time window.
[0083] FIG. 11A shows further details of the expanded dynamic range of an assay surface using digital detection according to the presently disclosed subject matter for an HIV p24 assay. As shown in FIG. 11A, an assay surface using digital detection responds to both low and high concentrations of analyte in an HIV p24 assay, for example, as shown from about 7.5 fg / mL up to 2000 pg / mL for a dynamic range of about 266,667 times (e.g., 2000 pg / mL divided by 7.5 fg / mL). For comparison with the presently disclosed subject matter, but not limited to, the assay range of the ARCHITECT™ HIV p24 assay is about a 5,000-10,000-fold dynamic range. In conventional systems, the dynamic range can be expanded by, for example, but not limited to, taking a first image at a higher concentration, diluting the sample, and taking a second image at a lower concentration. However, such a dilution process may involve additional processing time and steps to expand the dynamic range.
[0084] 11B shows further details of the expanded dynamic range of an assay surface using digital detection according to the presently disclosed subject matter for a TSH assay. As shown in FIG. 11B, an assay surface using digital detection responds to both low and high concentrations of analyte in a TSH assay over a dynamic range of about 163,934-fold (e.g., 50 μIU / mL divided by 0.000305 μIU / mL), as shown, for example, from about 0.000305 μIU / mL up to 50 μIU / mL. For purposes of illustration and comparison with the presently disclosed subject matter, but not by way of limitation, the assay range of the ARCHITECT™ TSH assay is 0.01 μIU / mL to 100 μIU / mL (e.g., a dynamic range of about 10,000-fold), which can be expanded to about 500 μIU / mL, for example, but not by way of limitation, by a dilution process.
[0085] According to other aspects of the presently disclosed subject matter, exemplary assay surfaces for use with exemplary assay processing units (APUs), assay processing systems (APSs), and laboratory systems are provided. Systems and methods for sample analysis can use any suitable components and techniques for sample processing and detection. For example, but not limited to, a pipette or system of pipettes can be used for all or part of sample processing and detection, for performing washing, mixing, or any other steps to form, separate, purify, or otherwise manipulate an analyte solution, for incubating or mixing the analyte solution with reaction components, and / or for moving the analyte solution to a detection site.
[0086] Additionally or alternatively, all or part of the sample processing and / or detection can be performed using a variety of reaction vessels and automated processes, including automated pipette systems that use suction or vacuum forces to manipulate the analyte solutions, or other automated systems that use other forces, such as magnetic forces or dielectrophoresis, to manipulate the analyte solutions.
[0087] Referring now to FIG. 12, by way of example and not by way of limitation, in one embodiment, an exemplary assay surface (1200) can be used in a sample analysis system according to the presently disclosed subject matter to perform all or part of sample processing and / or transfer of analytes to a region for detection in an applied magnetic field. By way of example and not by way of limitation, in one embodiment, the assay surface (1200) using magnetic forces as described herein can include a reaction tip made of a hydrophobic material. Alternatively, the assay surface according to the presently disclosed subject matter can be other suitable surfaces for sample preparation and detection. The assay surface (1200) can be configured as a series of regions through which microparticles can be moved by translation of a moving magnetic field, e.g., a moving magnet or electromagnet, parallel to the microparticles to perform various operations as described herein. Each region can be separated by a barrier or other separation mechanism, which can be an air-liquid interface, a liquid-immiscible liquid interface (e.g., separating an oil region from another liquid region), a valve, multiple stop elements, or any other suitable separation mechanism.
[0088] For example, but not by way of limitation, the assay surface (1200) includes a microparticle (mP or μP) storage area (1210) configured to hold one or more microparticles (or beads). In one embodiment, the microparticles (or beads) may already be stored in the storage area (1210). Alternatively, the microparticles (or beads) may be added to the assay surface manually or by an automated pipetting system from a larger reservoir of microparticles. As described herein, the microparticles (or beads) may be magnetic or paramagnetic to facilitate the use of magnetic forces to perform sample analysis. The microparticle storage area (1210) may be configured as a planar surface or may have a volume sized to hold an appropriate number of microparticles to perform sample analysis.
[0089] The assay surface (1200) can include a sample / conjugate mixing area (1220) extending from a microparticle storage area (1210). In one embodiment, the sample / conjugate mixing area (1210) can include preloaded reagents or conjugates. Additionally or alternatively, the reagents or conjugates can be added to the assay surface manually or by an automated pipetting system from a larger reservoir. The sample / conjugate mixing area (1220) can be configured to contain or accept one or more analytes of interest that bind to one or more microparticles that are moved into the sample / conjugate mixing area (1220). For example, but not limited to, the sample can be stored on the assay surface or moved to the sample / conjugate mixing area by manual or automated pipetting or any other suitable technique. The sample / conjugate mixing area (1220) can be configured as a planar surface or can have a volume sized to hold an appropriate number of samples, conjugates, enzymes, or other reagents that are used by the assay surface to detect the analytes of interest in the sample.
[0090] The assay surface (1200) can include one or more liquid bodies. For example, but not limited to, the assay surface (1200) can include an inert fluid region (1230) extending from the sample / conjugate mixing region (1220). In one embodiment, the inert fluid region (1230) can include, for example, mineral oil or other sample immiscible inert fluids that can promote sample droplet formation, increase sample droplet shape stability, and can be useful in maintaining the sample droplets and the microparticles spatially separated from each other. Additionally or alternatively, in one embodiment, the inert fluid region (1230) can be configured to perform a washing function, for example, but not limited to, removing excess aqueous solution from the microparticles by passing mineral oil through it. Additionally or alternatively, a washing step can be performed to remove other contaminants as described herein. In one embodiment, the mineral oil in the inert fluid region (1230) can be any suitable mineral oil (e.g., Nacalai Tesque Code 23306-84). Mineral oils can include mixtures of liquid hydrocarbons and can be derived from crude oils by distillation and refining. Other suitable oils for use in the inert fluid region (1230) can include fluorinated oils (e.g., FC-40) and organic oils (e.g., grapeseed oil, coconut oil, or cocoa oil).
[0091] The assay surface (1200) may also include one or more additional wash regions (1240, 1250), for example, but not limited to, extending from or in place of the inert fluid region (1230). The wash regions (1240, 1250) may each define a liquid body having an air-water interface at each end thereof. The wash regions may contain a solution, such as a buffer or any suitable solution, to remove unwanted contaminants or excess material, such as excess reagents or conjugates that do not bind to the analyte of interest or any microparticles or beads. Surface tension may be applied to the microparticles as they move through the air-water interface of the wash regions (1240, 1250) to remove the unwanted contaminants or excess material.
[0092] The assay surface (1200) can include a detection region (1260) extending from the washing regions (1240, 1250). For example, but not limited to, in one embodiment, the detection region (1260) can include an array of elements, each dimensioned to hold at least a single one of the microparticles or beads. For example, but not limited to, the array of elements can include an array of nanowells. Each nanowell can be sized to receive a single microparticle for single molecule detection. Alternatively, the detection region (1260) can be configured as a planar surface.
[0093] The assay surface (1200) may include one or more additional regions extending from the detection region (1260). For example, in one embodiment, the end region (1270) may include an encapsulated inert liquid region for storing an encapsulated inert liquid, such as an oil, used to encapsulate the detection region (1260). The end region (1270) may also include a dye region for storing a dye to darken the background and increase contrast for detection, which in one embodiment may be premixed with the oil. The end region (1270) may further include a waste region for removing particulates or any other used components from the assay surface (1200) for disposal.
[0094] By way of example and not limitation, in one embodiment, the assay surface (1200) can have a length of about 50 mm and a width of about 10 mm. Each region can have a width of up to about 6 mm, for example, in one embodiment. The exemplary assay surface (1200) can be used as part of an assay processing system (APS) in conjunction with an assay processing unit (APU) in a laboratory system according to the presently disclosed subject matter.
[0095] FIG. 13 illustrates an exemplary movement of microparticles along the assay surface (1200) through the liquid bodies corresponding to the regions. It will be apparent to one skilled in the art that various modifications and variations can be made to the methods and systems disclosed herein. As described herein, at least one moving magnetic field (1301) can be provided to urge the microparticles (1305) along the assay surface through the liquid bodies in the different regions and into the detection component of the assay surface. The moving magnetic field (1301) can be generated by a magnetic element located at any suitable position relative to the assay surface. By way of example, the magnetic element can be located above the assay surface, below the assay surface, beside the assay surface, or in any other suitable location. By way of example and not by way of limitation, in one embodiment, the at least one moving magnetic field (1301) can be a moving magnet. Alternatively, the moving magnetic field (1301) can be generated by, for example, an electromagnet. By way of example and not by way of limitation, in one embodiment, the moving magnetic field (1301) is located below the assay surface. Alternatively, the moving magnetic field (1301) can be located at any other suitable location. In one embodiment, some or all of the surface of the assay surface (1200) may be made of a hydrophobic material that may prevent or inhibit undesired movement of liquid between regions, for example but not limited to, surface tension may be applied as microparticles move through air-liquid or air-oil interfaces in various regions from sample processing to detection.
[0096] 14-15 show different embodiments of assay surfaces having different configurations according to the subject matter of the present disclosure. Referring to FIG. 15, the assay surface (1500) can include five regions. Microparticles or beads are moved by magnetic forces along the length of the assay surface (1500) through each region of the assay surface (1500) and into the detection region (1550). For illustrative purposes only, the magnetic axis is shown in FIG. 15 as being below the assay surface (1500). Alternatively, the magnetic force can be generated by a magnetic element at other suitable locations, such as above the assay surface (1500) or to the side of the assay surface (1500).
[0097] As shown in Figure 15, in one embodiment, the assay surface (1500) can include a sample area (1510). The sample area (1510) includes microparticles that are mixed with a sample having an analyte of interest (antigen), for example, by pipetting or any other suitable technique. Alternatively, the sample area (1510) can be preloaded with microparticles. In the sample area (1510), for example, the microparticles can bind to a single antigen in the sample as a first binding partner.
[0098] The assay surface (1500) can include a wash region (1520) extending from the sample region (1510). As described herein, a single wash region (1520) is implemented, although additional wash regions can be included. The wash region (1520) can be configured to remove undesired contaminants and / or unbound analytes from the microparticles as described herein.
[0099] The assay surface (1500) can include a conjugate / enzyme region (1530) extending from the wash region (1520). By way of example, the region (1530) can include a reagent or conjugate, or the reagent or conjugate can be added to the region manually or automatically, for example, using a pipettor. In the conjugate / enzyme region (1530), the analyte (antigen) bound to the microparticle can bind to another analyte-specific binding partner as a second binding partner that is labeled to generate a signal for detection.
[0100] The assay surface (1500) can include a wash region (1540) extending from the conjugate / enzyme region (1530). As described herein, a single wash region (1540) is implemented, although additional wash regions can be included. The wash region (1540) can be configured to remove unbound conjugate / reagents as described herein.
[0101] The assay surface (1500) can include a detection region (1550) extending from the wash region (1540). In one embodiment, the detection region (1550) can be configured as a digital detection region. Alternatively, the detection region (1550) can be configured for other suitable detection, such as analog detection. The detection region (1550) can include one or more nanowells configured for detection. Alternatively, the digital detection region can be configured as a planar surface. Additionally or alternatively, by way of example and not limitation, the detection region (1550) can include other regions where particulates are detected and / or imaged, including the use of nanowells, nanopores, fluorescent detection regions, or any other suitable regions for detection of analytes in an assay. The exemplary assay surfaces described herein can be formed from any suitable material, such as, but not limited to, PTFE sheet or any other suitable material, such as, for example, cyclic olefin polymer (COP), PMMA, or other hydrophobic materials.
[0102] The exemplary assay surfaces described herein can be used to perform sample processing, including, for example, but not limited to, any of the sample processing steps described herein. FIG. 16A shows an exemplary washing efficiency of an HBsAg assay performed using an assay surface according to the presently disclosed subject matter. For example, but not limited to, 75 μL of a negative sample (recalcified plasma) and HBsAg assay beads were incubated for 18 minutes. After incubation, the beads were attracted and moved on the hydrophobic surface by a moving magnetic field. A washing process was performed by passing the collected beads through a 10 μL buffer droplet using a magnetic field. Up to four washes were performed during the assay. As shown in FIG. 16A, after the first wash, a signal percentage of 0.08 was obtained. After the second wash, a signal percentage of 0.03 was obtained, which may be suitable for digital detection as described herein. The signal percentage can be considered as the percentage of beads with bright droplets counted from the total number of collected beads, and can be determined, for example, but not limited to, by the following formula: That is, NbD / NtB×100%, where NbD and NtB refer to the number of beads with bright droplets and the total number of collected beads, respectively. Additional washings caused smaller changes in the signal percentage obtained. Thus, two washings may be suitable for performing an assay using the assay surface according to the presently disclosed subject matter, and the total washing time may be about 30 seconds.
[0103] FIG. 16B shows an exemplary collection efficiency using an assay surface according to the presently disclosed subject matter. As shown in FIG. 16B, an assay surface according to the presently disclosed subject matter can have a collection efficiency ratio (e.g., number of microparticles remaining after assay) of greater than 90%, indicating adequate collection of microparticles using an assay surface disclosed herein. With reference to FIG. 16B, the column labeled "- / - / - / -" shows beads that were initially untreated (e.g., 100% collection ratio). The column labeled "10fM / + / - / -" shows collection ratios of beads with an assay surface of a 75 μL sample according to the presently disclosed subject matter (e.g., greater than 90% collection ratio). The column labeled "10fM / - / + / -" shows collection ratios of beads with a 75 μL sample without an assay surface according to the presently disclosed subject matter and without conjugate (e.g., about 90% collection ratio). The column labeled "10 fM / + / + / +" shows the collection ratio of beads (e.g., about 90% collection ratio) from an HBsAg assay using an assay surface according to the presently disclosed subject matter and a 75 μL sample incubated and conjugated. Thus, a high percentage of the microparticles are retained by the assay surface according to the presently disclosed subject matter as the microparticles are moved along various regions of the assay surface.
[0104] As described herein, detection according to the presently disclosed subject matter can be performed using smaller sample volumes, smaller amounts of reagent materials and volumes, smaller amounts of conjugate materials, smaller amounts of nanoparticles, or any combination thereof, which can reduce the cost of performing each assay. Thus, sample preparation time can be improved, at least in part due to fewer sample manipulations involved. Smaller sample volumes can also provide certain reaction kinetics improvements to improve sample processing speed during incubation or amplification reactions or other reactions performed using such sample volumes. In one embodiment, a sample analysis system using exemplary assay surfaces according to the presently disclosed subject matter can be configured to improve processing times for smaller amounts of sample, conjugates, and / or microparticles.
[0105] The sample processing systems and techniques described herein can be used to perform sample processing on small sample volumes, such as, but not limited to, about 10 μL or less. Alternatively, the sample volume for the exemplary assay surfaces can be about 10 μL to about 50 μL. Alternatively, the sample volume for the exemplary assay surfaces can be less than 50 μL. Alternatively, the sample volume for the exemplary assay surfaces can be less than 75 μL. Alternatively, the sample volume for the exemplary assay surfaces can be less than 100 μL. Additionally or alternatively, the exemplary assay surfaces according to the presently disclosed subject matter can achieve faster wash times, including when used with small sample volumes. In comparison, some conventional sample analysis systems may not be suitable for use with sample volumes less than 100 μL.
[0106] Additionally or alternatively, the sample processing systems and techniques described herein can be used to perform sample processing using small wash buffer volumes, such as, but not limited to, about 10 μL or less. Alternatively, the buffer volume for the exemplary assay surface can be about 10 μL to about 50 μL. Alternatively, the wash buffer volume for the exemplary assay surface can be less than 50 μL. Alternatively, the wash buffer volume for the exemplary assay surface can be less than 75 μL. Alternatively, the wash buffer volume for the exemplary assay surface can be less than 100 μL. Additionally or alternatively, the exemplary assay surfaces according to the presently disclosed subject matter can achieve faster wash times, including when used with small sample volumes. In comparison, some conventional sample analysis systems may not be suitable for use with wash buffer volumes less than 100 μL.
[0107] Additionally or alternatively, the sample processing systems and techniques described herein can be used to perform sample processing using small reagent volumes, such as, but not limited to, about 10 μL or less. Alternatively, the reagent volumes for the exemplary assay surfaces can be about 10 μL to about 50 μL. Alternatively, the reagent volumes for the exemplary assay surfaces can be less than 50 μL. Alternatively, the reagent volumes for the exemplary assay surfaces can be less than 75 μL. Alternatively, the reagent volumes for the exemplary assay surfaces can be less than 100 μL. Additionally or alternatively, the exemplary assay surfaces according to the presently disclosed subject matter can achieve faster wash times, including when used with small sample volumes. In comparison, some conventional sample analysis systems may not be suitable for use with reagent volumes less than 100 μL.
[0108] By way of example and not by way of limitation, FIG. 17 shows exemplary results of an assay performed by a sample analysis system using an exemplary assay surface according to the presently disclosed subject matter with a sample volume of 10 μL compared to an assay performed by a conventional sample analysis system (e.g., Abbott ARCHITECT™) with a sample volume of 100 μL (per instructions for use). Alternatively, the exemplary assay surface can have a sample volume of less than 100 μL. For example and not by way of limitation, a conventional HIV p24 assay with a sample volume of 100 μL was performed with 25 μL of 9.6 ug / mL conjugate and 25 μL of 800k assay beads within an immunoreaction time of 18 minutes. By way of example and not by way of limitation, a HIV p24 assay with a sample volume of 10 μL using an assay surface according to the presently disclosed subject matter was performed with 3.125 μL of 75 ug / mL conjugate and 3.125 μL of 200k assay beads within an immunoreaction time of 4 minutes.
[0109] Reducing the sample volume used with conventional systems from 100 μL to 10 μL (e.g., about 10-fold) would be expected to result in a corresponding decrease in sensitivity of about 10-fold (e.g., from an S / N of 33 to an S / N of less than 4). However, as shown in FIG. 17, a configuration using a 10 μL sample volume with an assay surface according to the presently disclosed subject matter achieves an S / N ratio of about 15, which is comparable to an S / N ratio of about 33 for a conventional system using 100 μL sample, and may be suitable for optical detection, including but not limited to analog or digital detection techniques described herein. This S / N ratio achieved using a 10 μL sample volume with an assay surface according to the presently disclosed subject matter may be at least in part due to improved kinetics obtained during immune reactions occurring in smaller sample volumes. Providing a reduced sample volume prepared using smaller amounts of reagents at concentrations suitable for digital detection may allow for cost savings for each assay performed using a system for sample analysis according to the presently disclosed subject matter.
[0110] According to another aspect of the presently disclosed subject matter, an exemplary laboratory system, assay processing unit (APU) or assay processing system (APS) can be constructed. By way of example and not by way of limitation, in one embodiment, the exemplary sample analysis systems and methods can use the exemplary assay surfaces described herein to achieve high throughput, including but not limited to time per sample, number of samples over time, and number of samples over time per area (footprint) of the system.
[0111] FIG. 18 shows further details of an exemplary laboratory system including multiple APSs disclosed herein compared to conventional sample detection systems (e.g., Abbott Alinity i and Abbott ARCHITECT™ i2000SR) for purposes of illustrating and validating the subject matter of the present disclosure. As shown in FIG. 18, by way of example and not by way of limitation, the exemplary laboratory system can achieve an areal throughput of approximately 560 tests per square meter per hour with a much smaller footprint of 0.96 square meters for the core sample preparation and detection components. By way of example and not by way of limitation, the exemplary laboratory system can include one or more exemplary APSs and a controller configured to control multiple of the one or more APSs to process corresponding samples and to detect the presence of at least one corresponding analyte or determine the level or concentration of at least one analyte in a substantially parallel manner. The exemplary laboratory system can process multiple assay surfaces in a compact footprint. In comparison, the Abbott Alimity™ i system and the Abbott ARCHITECT™ i2000SR system have area throughputs of approximately 140 tests per hour per square meter of footprint and approximately 100 tests per hour per square meter of footprint, respectively.
[0112] FIG. 19 illustrates further details of an embodiment of an exemplary APS for use in an exemplary laboratory system and method for sample analysis with an area throughput of about 560 tests per hour per square meter of footprint according to the subject matter of the present disclosure, as illustrated in FIG. 18 using the assay surfaces described herein. By way of example and not by way of limitation, the exemplary laboratory system may include one or more exemplary APSs and a controller configured to control a plurality of the one or more APSs to process corresponding samples and detect the presence of at least one corresponding analyte or to make substantially parallel determinations of the level or concentration of at least one corresponding analyte. The exemplary laboratory system may process multiple assay surfaces in a compact footprint. By way of example and not by way of limitation, in one embodiment, the exemplary APS may include one or more exemplary assay surfaces and an exemplary assay processing unit (APU), as illustrated in FIG. 19. By way of example and not by way of limitation, the exemplary APU may include a control board including one or more processors configured to control operation, LED lights, an optical unit, a CMOS image sensor for detection, an assay surface receiving component, and a magnetic element for generating a magnetic field. By way of example and not limitation, the exemplary processors described herein can be configured to perform operations using hardware logic, firmware, or software instructions. By way of example and not limitation, the magnetic element can be an electromagnet generating a moving magnetic field or a magnet operatively connected to the sliding element. By way of example and not limitation, the sliding element can be a motor. Additionally or in addition to the above, the magnetic element can be positioned in any suitable position relative to the received assay surface. In one embodiment, the exemplary APS in FIG. 19 is relatively compact yet performs testing with desired sensitivity in a short period of time, such as, but not limited to, about 5.5 minutes.In one embodiment, multiple APSs of FIG. 19, having a footprint of approximately 0.005 square meters, for example, but not limited to, approximately 52, can be packaged together into a single instrument, enabling a high throughput instrument as an exemplary laboratory system in a reasonable footprint of approximately 0.26 square meters, in one embodiment.
[0113] By way of example and not by way of limitation, in one embodiment, the exemplary assay processing system (APS) can include a receiving component as a process path to receive one or more assay surfaces to process the assay surfaces to reduce the total time to result of the sample to less than 6 minutes, and alternatively, the time to result can be 3-5 minutes for a one-stage assay, or 3-7 minutes for a two-stage assay. Or, the time to result can be 2-5 minutes. Or, the time to result can be 5-10 minutes. Or, the time to result can be less than 5 minutes. Or, the time to result can be less than 10 minutes. In one embodiment, the exemplary assay surface can enter a one-stage assay receiving component of the APS. By way of example and not by way of limitation, there can be different receiving components (process paths) to accommodate different assay protocols. For example and not by way of limitation, the exemplary assay surfaces (1200) or (1500) can be loaded from a storage unit of the exemplary APS. Sample can be applied to the assay surface for about 10 seconds, for example, by automated or manual pipetting or any other suitable technique. By way of example and not limitation, samples, microparticles or reagents / conjugates can be stored on the assay surface for use or can be added manually or automatically from reservoirs, for example using pipetting or other suitable techniques. A liquid mass containing the analyte can be prepared on the assay surface and various sample processing steps can be performed, including, for example, mixing, washing and / or incubation steps, including, but not limited to, washing the sample-microparticle complex, adding conjugates to the sample, and adding substrates to the sample. Oil can be added to the sample at one station and a first image can be captured under control of the processor of the APU, which can be used to expand the dynamic range of detection at higher concentrations. The total sample processing time for these processes can be approximately 3.5 minutes.After the first image, an enzyme can be added to the imaged sample and the sample can be incubated for an enzyme reaction time to obtain a concentration suitable for digital detection. Under control of a processor, multiple images of the incubated sample can be acquired and the images can be used to determine the presence, absence or concentration of the analyte at lower concentrations. The total sample processing time through the determination of the presence of the analyte in the sample is less than 6 minutes and in some embodiments the time to result can be 3-5 minutes. By way of example and not limitation, the following table summarizes an example of a one-step assay process resulting in a test time of about 5.5 minutes. In the configuration of FIG. 19 packaged in 52 multiple units with associated sample, reagent and disposable handling systems in a single instrument for laboratory systems for parallel processing, the total throughput per hour for the one-step assay process is, in one embodiment, about 572 tests per hour in a single instrument with a footprint of about one square meter. Additional units can be packaged within the same single instrument footprint to achieve more tests per hour, including 400, 500 or 600 tests per hour, or can be configured to achieve throughputs ranging from 375 to 600 tests per hour.
[0114] [Table 1]
[0115] By way of example and not by way of limitation, a two-step assay can alternatively or additionally be performed on the process pathway. The time to result can be 3-7 minutes. Or, the time to result can be less than 5 minutes. Or, the time to result can be less than 10 minutes. The following table summarizes an example of a two-step assay process resulting in a test time of about 7 minutes. By way of example and not by way of limitation, the sample, microparticles or reagents / conjugates can be stored on the assay surface for use or can be added manually or automatically from a reservoir using, for example, pipetting or other suitable techniques. In the example APS of the configuration of FIG. 19 packaged in 67 multiple units with associated sample, reagent and disposable handling systems in a single instrument in the example laboratory system, the total throughput per hour for the two-step assay process is, in one embodiment, about 570 tests per hour in a single instrument with a footprint of about 1 square meter. Additional units can be packaged within the same footprint in a laboratory system to achieve more tests per hour, including 400, 500 or 600 tests per hour, or can be configured to achieve throughputs ranging from 375 to 600 tests per hour.
[0116] [Table 2]
[0117] By way of example and not limitation, an exemplary laboratory system may be configured to perform one or more of an HIV p24 assay, an HBsAg assay, a Troponin I assay, a TSH assay, a myoglobin assay, a PSA assay, a BNP assay, a PIVKA-II assay, an HIV Ab assay, an estradiol assay, a COVID-Ag assay, and other assays.
[0118] FIG. 20 illustrates an exemplary assay surface (2000) of the disclosed systems and methods for preparation and detection of an analyte of interest in a sample. As shown, the exemplary assay surface (2000) can include an upper portion (2010) and a lower portion (2020). The upper portion (2010) can cover and seal the lower portion (2020) when preparing and detecting an analyte of interest. By way of example and not limitation, the exemplary assay surface can include multiple regions and multiple channels in the lower portion (2020), each of which can be arranged in series to define a sample preparation and detection zone (2040). In one embodiment, the exemplary assay surface (2000) can include a sample preparation and detection zone (2040) having a particulate storage region (2022), a sample storage region (2024), a sample / conjugate mixing region (2026), one or more wash regions (2028), and a detection region (2032). In one embodiment, the exemplary assay surface (2000) has three wash regions (2028). In one embodiment, the surface of the lower portion (2020) may be made of a hydrophobic material, such as COP.
[0119] By way of example and not limitation, in one embodiment, the microparticle storage area (2022) can contain a plurality of microparticles. Alternatively, the microparticles can be loaded into the area manually or automatically from a microparticle reservoir, for example using a pipettor. As described herein, the microparticles can be magnetic or paramagnetic to facilitate the use of magnetic forces to perform sample analysis and detection. Additionally or alternatively, the magnetic or paramagnetic beads or particles can specifically bind to the analyte or reagent / conjugate of interest. The microparticles can move through the area of the exemplary assay surface under magnetic forces. By way of example, the magnetic forces can be a magnetic field generated by an assay processing unit (APU) as disclosed herein.
[0120] Additionally or alternatively, the sample storage area (2024) may contain an analyte of interest for preparation and detection in a suitable solution. In one embodiment, the analyte of interest may be, for example, an HIV Ab p24 assay, an HIV1-Ab assay, an HBsAg assay, or a COVID-Ag assay. Or, the analyte of interest may include other analytes.
[0121] By way of example and not by way of limitation, the sample / conjugate mixing area (2026) can be configured to mix the analyte of interest with microparticles and / or reagents / conjugates. In one embodiment, the reagents or conjugates can be stored in the mixing area (2026). Alternatively, the reagents or conjugates can be loaded into the area manually or automatically from a larger reservoir, for example using a pipettor. By way of example and not by way of limitation, in one embodiment, the analyte of interest for an HIV Ab p24 assay can be mixed with paramagnetic beads (800k beads) and an enzymatic nCIAP-anti-p24 conjugate.
[0122] Additionally, one or more wash regions (2028), if provided, can be sized to accommodate one or more wash buffers for removing unbound analytes of interest. In one embodiment, the wash regions can be used to remove molecules that are not bound to any of the particles. The exemplary assay surface (2000) can include any number of wash regions, which in one embodiment can include three wash regions. In the exemplary assay described herein, the wash period for each wash region can be about 90 seconds.
[0123] By way of example and not by way of limitation, the detection region (2032) can be configured for detection of an analyte of interest. The detection region (2032) can be configured for analyte detection using any of the analyte detection techniques described herein. By way of example and not by way of limitation, exemplary analyte detection techniques can include one or more of optical detection, analog signal detection, digital signal detection, illumination detection, fluorescence detection, or any combination of these techniques. Additionally or alternatively, the detection region (2032) can be configured for single molecule counting. Also by way of example and not by way of limitation, the detection region can include a plurality of elements, each dimensioned to hold at least a single bead or particle. In one embodiment, the array of elements can include an array of nanowells configured for detection by separating microparticles bound to the analyte of interest into a plurality of nanowells. By way of example and not by way of limitation, in one embodiment, the microparticles or beads can be loaded into a plurality of nanowells using magnetic forces. The use of magnetic forces to load the microparticles into the plurality of nanowells can improve the efficiency and accuracy of loading. By way of example and not limitation, in one embodiment, most of the array of nanowells can be loaded with at least one microparticle, thereby improving the efficiency of single molecule detection.
[0124] 21 illustrates a front perspective view of an exemplary assay processing unit (APU) (2100) for preparing and detecting an analyte of interest in a sample using an exemplary assay surface in an assay processing system (APS) according to the presently disclosed subject matter. By way of example and not limitation, in one embodiment, the exemplary APU (2100) can include a processor (2110), a magnetic element (2115), a detection region (2120), an assay surface receiving component (2150), and a detection component (2125). The exemplary APS can include one or more exemplary assay surfaces and an exemplary APU.
[0125] With further reference to FIG. 21, the processor (2110) may include a control board configured to perform operations on the assay surface, the detection component (2125), and to control the movement of other components of the exemplary APU (2100). By way of example and not limitation, the processor (2210) may include an Arduino Micro computer system. In one embodiment, the detection component (2125) may include a camera and a light source, such as an LED, arranged to perform optical detection of the analyte of interest. Alternatively, the detection component may include other suitable instruments for other types of detection. In one embodiment, the assay surface (2130) received in the assay surface receiving component (2150) may be the exemplary assay surface (2000) as disclosed above. Alternatively, the received assay surface (2130) may be other assay surfaces.
[0126] By way of example and not limitation, the magnetic element (2115) of the exemplary APU may include an electromagnet that generates a moving magnetic field. Alternatively, in one embodiment, the magnetic element (2115) may include a magnet operably connected to a sliding mechanism (2140). The sliding mechanism (2140) may be controlled by the processor (2110) and may move the magnet horizontally, for example, by a motor. Additionally or alternatively, the magnetic element (2115) may be located in any suitable location relative to the received assay surface (2130). For example, the magnetic element (2115) may be below or above the assay surface (2130) or to the side of the assay surface (2130). By way of example only, FIG. 21 illustrates the magnetic element (2115) below the assay surface (2130).
[0127] FIG. 22 shows a side view of the example APU (2100) of FIG. 21. In one embodiment, the APU (2100) can include the detection component (2125), the drive element (2210), and a stepper motor (2220) for the sliding mechanism (2140). By way of example and not by way of limitation, the magnetic element (2115) can be an electromagnet that generates a moving magnetic field in a horizontal or vertical direction defined by the top surface of the received assay surface. Alternatively, in one embodiment, the magnetic element (2115) can be a magnet. The drive element (2210) can be operatively connected to the magnet to move the magnet in a vertical direction defined by the top surface of the received assay surface. By way of example, the drive element (2115) can be a motor or a string. Additionally or alternatively, the APU can also include a mixing dynamics component, which can include an electromagnet, an ultrasonic mixing element, a ballistic mixing element with a pipetter, or other suitable element to enhance mixing frequency. The mixing kinetics component can mix at least one liquid body disposed on an assay surface received by the APU and the APS at a predetermined frequency. By way of example and not by way of limitation, in one embodiment, the mixing kinetics element can be a vibration motor.
[0128] By way of example and not by way of limitation, the detection component (2125) can be configured for detection of an analyte of interest using optical detection and can include, for example, a camera and a light source such as an LED. By way of example and not by way of limitation, in one embodiment, if the magnetic element (2115) is a magnet, the drive element (2210) can be connected to the magnet by a nut-bolt connection and can move the magnet towards and away from the assay surface in a vertical direction perpendicular to a plane defining the top surface of the received assay surface. Alternatively, the magnetic element (2115) can be an electromagnet that generates a moving magnetic field in a vertical direction. In one embodiment, the direction of movement of the magnet is perpendicular to a plane defined by the top surface of the received assay surface (2130).
[0129] 23A and 23B show the movement of a plurality of microparticles in a droplet in a wash region of an exemplary assay surface under the magnetic force of a magnetic element, with other regions and features of the assay surface described herein omitted in this schematic view for illustrative purposes only. In one embodiment, the exemplary assay surface (2301) can include three wash regions (2310). The magnetic element (2315) can generate a moving magnetic field in a vertical direction from a plane defined by the upper surface of the assay surface (2301). Additionally or alternatively, the magnetic element (2315) can be located in any suitable location, for example, above or below the assay surface (2301) or to the side of the assay surface (2301). In one embodiment, by way of example, the magnetic element (2315) can be a magnet located below the assay surface (2301). The magnet can be connected to a drive element (not shown), for example a motor. The drive element can move the magnet in a vertical direction toward and away from the assay surface. Alternatively, the magnetic element (2315) can be one or more electromagnets that generate a moving magnetic field in a vertical direction. Also, in one embodiment, there is a droplet with particles (2305) in one of the washing regions. The droplet can contain particles that are moved under the magnetic force of the magnetic element (2315).
[0130] As shown in FIG. 23B, in one embodiment, when a magnet is brought closer to the assay surface (2301), the droplets (2305) with the microparticles can be attracted toward the magnet and accumulate relatively closer to the magnet. When the magnet is moved away from the assay surface (2301), the droplets (2305) with the microparticles can spread relatively farther away from each other under the smaller force from the magnet. By way of example and not by way of limitation, the magnet can be moved about 5 mm away from the lower surface of the assay surface (2301). Alternatively, the moving magnetic field can be generated by the electromagnet without changing the position of the electromagnet. By way of example, in one embodiment, when the magnet is closest to the assay surface (2301), the distance between the assay surface (2301) and magnet Z1 can be about 0 mm. By way of example, in one embodiment, when the magnet is farthest from the assay surface (2301), the distance between the assay surface (2301) and magnet Z2 can be about 5 mm. Also, in one embodiment, for each cleaning zone, the magnets can be moved up and down about four times to improve cleaning efficiency. Alternatively, the moving magnetic field of the magnetic element (2315) can be generated by an electromagnet controlled by one or more processors of the APU.
[0131] 24A-24D show another exemplary assay surface having multiple stop elements. In one embodiment, the exemplary assay surface can include an upper portion (2401), a lower portion (2410), and multiple stop elements (2405). As shown in FIG. 24A, in one embodiment, the lower portion (2410) can include multiple regions and multiple channels that define a sample separation and detection zone (2440) as disclosed by the present subject matter, by way of example and not by way of limitation. For example, the channel (2420) is between a first region (2422) and a second region (2424). By way of example and not by way of limitation, the first region can be configured to store microparticles and the second region can be configured to store an analyte of interest in an appropriate solution. Alternatively, the microparticles or analytes can be loaded manually or automatically from a reservoir. In one embodiment, the surface of the lower portion (2410) can include a hydrophobic material, such as COP, as described herein.
[0132] As shown in FIG. 24B, by way of example and not limitation, multiple stop elements (2405) can be inserted into multiple channels in the lower portion (2410). As shown in FIG. 24C, in one embodiment, multiple regions in the lower portion (2410) can contain solutions and droplets for preparation and detection of analytes of interest. Additionally or alternatively, region (2415) can contain multiple microparticles that bind to the analytes of interest. As shown in FIG. 24D, the upper portion (2401) can cover the lower portion (2410) and multiple stop elements (2405) to define a reaction compartment, and can be joined to seal the reaction compartment and protect the reaction compartment from undesired ingress or egress of substances into or from the reaction compartment.
[0133] By way of example and not limitation, the plurality of stop elements (2405) can be made of a hydrophobic material, such as rubber. Multiple regions of the assay surface can store different compositions or solutions, and when multiple stop elements are disposed in multiple channels, the multiple stop elements can prevent or inhibit undesired migration of contents of a region to a different region, for example and not by way of limitation, during shipping, storage, and handling of the assay surface.
[0134] 20-22, an exemplary sample preparation and detection system (assay processing system (APS)) and method is disclosed with reference to and use of an exemplary assay surface (2000) and an exemplary APU (2100). Alternatively, the APS may include a separate assay surface and a separate APU. By way of example and not by way of limitation, in one embodiment, the analyte of interest may be an HIV Ag p24 assay. First, a suitable solution is loaded onto the lower portion (2020) of the assay surface (2000). By way of example and not by way of limitation, in one embodiment, the suitable solution may be a serum sample.
[0135] In one embodiment, the microparticle storage area (2022) can contain paramagnetic beads capable of binding to an HIV Ag assay, such as MS300 beads. Alternatively, the microparticles can be loaded manually or automatically from a reservoir. The sample storage area (2024) can contain an assay for HIV Ag p24 in a suitable solution. The sample / conjugate mixing area (2026) can contain suitable conjugates and reagents for immune and / or enzymatic reactions, such as an enzymatic nCIAP anti-p24 conjugate (1 AP / conjugate). Alternatively, the reagents / conjugates can be loaded manually or automatically from a larger reservoir. The total solution volume of the microparticle storage area (2022), sample storage area (2024), and sample / conjugate mixing area (2026) can be about 15 μL. The total volume capacity of the microparticle storage area (2022), sample storage area (2024), and sample / conjugate mixing area (2026) can be about 25 μL or less. The plurality of wash regions (2028) can each contain about 10 μL of wash buffer. The detection region (2032) can include a plurality of elements, each dimensioned to hold at least a single one of the microparticles. In one embodiment, the detection region (2032) can include an array of nanowells configured for analyte detection. The detection region (2032) can include 50 μL of AP substrate buffer. After the assay surface (2000) is loaded, the plurality of stop elements can be inserted into the plurality of channels (2036), and the upper portion (2010) can cover the lower portion with the plurality of stop elements.
[0136] The assay surface (2000) can be placed in an assay surface receiving component of the exemplary APU (2100). A magnetic element (2115) can generate a moving magnetic field. By way of example and not limitation, in one embodiment, the magnetic element (2115) can include a magnet, and a sliding mechanism (2140) can move the magnet horizontally.
[0137] Two of the multiple stop elements can be removed from the channel between the microparticle storage area (2022) and the sample storage area (2024) and the channel between the sample storage area (2024) and the sample / conjugate mixing area (2026). If the APU includes a mixing kinetics element, such as a vibration motor, the mixing kinetics element can vibrate the solutions and droplets in the microparticle storage area (2022), the sample storage area (2024), and the sample / conjugate mixing area (2026) at a predetermined frequency, thereby promoting the binding of the paramagnetic beads to the analyte of interest, HIV Ag p24. In one embodiment, the vibration motor can vibrate the solutions in these areas for approximately 110 seconds, sufficient for the immune reaction to occur. Alternatively, the mixing kinetics element can include an electromagnet to promote mixing under a magnetic field. By way of example and not limitation, for the analyte of interest, HIV Ag p24, the positive and negative signals received in the detection area of the exemplary assay surface after mixing and enzymatic reaction can be compared to signals received based on a manual assay.
[0138] In one embodiment, a stepper motor (2220) can move the magnet from the sample / conjugate mixing region (2026) to the first wash region (2028). Alternatively, the magnetic element (2115) can be one or more electromagnets that generate a moving magnetic field along the length of the assay surface. One of the multiple stop elements (not shown) can be removed from the channel between the sample / conjugate mixing region (2026) and the first of the multiple wash regions (2028). In one embodiment, a drive element (2210) connected to the magnet can move the magnet toward and away from the first wash region. In one embodiment, the magnet can move up and down four times. Alternatively, this can be achieved by one or more electromagnets that generate a moving magnetic field in a vertical direction. Similar techniques as described herein can be performed, for example, for the second and third and any additional wash regions, to prepare the sample for detection. After washing, the paramagnetic beads bound to HIV Ag p24 can be moved into the detection region (2032). In one embodiment, the detection region (2032) can include an array of nanowells. Illustratively, loading of microparticles or beads into the nanowells can be under magnetic force. The magnetic force can be generated by a magnetic element (2115) of an illustrative APU. The magnetic element can be a magnet or an electromagnet. Illustratively, loading of beads or microparticles under magnetic force can improve efficiency and accuracy. Furthermore, multiple passes or movements of microparticles across the detection region (2032) can increase the loading rate in the nanowells. Additionally or alternatively, an inert liquid, such as oil, can be dispensed to seal the nanowells for detection. In one embodiment, the nanowells can be sealed by about 150 μL of oil dispensed from an oil reservoir (not shown), such as a syringe oil pump.
[0139] With further reference to FIGS. 20-22, in one embodiment, the detection area (2032) of the assay surface (2000) can be imaged in the detection area (2120) of the APU by the detection component (2125) of the APU. By way of example and not by way of limitation, the detection component (2125) can include a camera configured to record or measure optical signals from a plurality of nanowells having analytes of interest and particulates therein. By way of example and not by way of limitation, one or more processors of the exemplary APU can cause the detection component (2125) to acquire a series of images of the detection area (2032) of the exemplary assay surface. In one embodiment, the detection component (2125) can count individual signals from each of the plurality of nanowells or the surface of beads within each of the plurality of nanowells to perform single molecule counts every 30 seconds. Additionally or alternatively, the detection component (2125) can measure the intensity of the optical signal indicative of the presence or concentration of an analyte in the nanowell.
[0140] In one embodiment, for example and not by way of limitation, after 2 minutes of immunological reaction and 1.5 minutes of enzymatic reaction at 37° C. for an HIV Ag P24 assay (600 fg / ml), the exemplary system as disclosed above can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system. For example and not by way of limitation, the total assay preparation time for an HIV Ag p24 assay can be about 5.5 minutes. For example and not by way of limitation, after 2 minutes of immunological reaction and 3 minutes of enzymatic reaction at 37° C., the exemplary system as disclosed above can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system. For example and not by way of limitation, the total assay preparation time for an HIV AG p24 assay can be about 7 minutes. For HBsAg assay (1 fM), after 2 minutes of immune reaction and 2 minutes of enzyme reaction at 37°C, the exemplary system as disclosed above can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system. For COVID-Ag assay (10,000 cp / ml), after 2 minutes of immune reaction and 1.5 minutes of enzyme reaction at 37°C, the exemplary system as disclosed above can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system. By way of example and not by way of limitation, the total assay preparation time for COVID-Ag assay can be about 5.5 minutes. In one embodiment, by way of example and not by way of limitation, the sample volume of the exemplary system can be 10 μL and the reagent assay volume of the exemplary system can be 15 μL. Alternatively, the sample volume for the exemplary system can be about 10 μL to about 50 μL. Alternatively, the sample volume of the exemplary system can be less than 50 μL. Alternatively, the sample volume of the exemplary system can be less than 75 μL. Alternatively, the sample volume of the exemplary system can be less than 100 μL.
[0141] Or, in one embodiment, for an HIV Ag p24 assay (600 fg / ml), the exemplary system can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system, with a total assay preparation time of 5.5 minutes, including 2 minutes of immune reaction time and 1.5 minutes of enzyme reaction. In one embodiment, for a COVID-Ag assay (10,000 cp / ml), the exemplary system can achieve comparable detection sensitivity compared to conventional sample preparation and detection devices, such as the Abbott ARCHITECT™ system, with a total assay preparation time of 5.5 minutes, including 2 minutes of immune reaction and 1.5 minutes of enzyme reaction.
[0142] 25 shows an exemplary assay surface (2500) according to the presently disclosed subject matter. In one embodiment, an upper portion (2560) of the assay surface (2500) covers a plurality of stop elements (2505) and a lower portion (2570) of the assay surface (2500). In one embodiment, the lower portion (2570) can include a plurality of regions and a plurality of channels that define a sample preparation and detection zone (2580). For example, the plurality of stop elements (2505) are disposed within one channel (2515).
[0143] In one embodiment, the microparticle storage area (2523) of the lower portion (2570) can be configured to store a plurality of microparticles. Alternatively, the microparticles can be loaded into area (2523). The sample storage area (2525) of the lower portion (2570) can be configured to store an analyte of interest in a suitable solution. The sample / conjugate mixing area (2527) of the lower portion (2570) can be configured to mix a sample with the microparticles and reagents and / or conjugates. Alternatively, the reagents / conjugates can be added to area (2527). In one embodiment, the lower portion (2570) can include one or more wash areas (2530). By way of example and not limitation, the lower portion (2570) includes three wash areas. In one embodiment, the lower portion can include a detection area (2535) configured for detection of an analyte of interest. Additionally or alternatively, the detection area can include an optical detection area, a plurality of nanowells configured for digital detection of an analyte, or any other suitable detection component. By way of example and not limitation, when a sample is analyzed, microparticles can be moved under magnetic force through these regions into a detection region (2535).
[0144] In one embodiment, the assay surface may further include an inert liquid reservoir (2540). The inert liquid reservoir may be configurable to disperse an inert liquid, such as an oil, to seal at least one of the regions. Additionally or alternatively, the inert liquid reservoir (2540) may include a liquid inlet (2545) for dispensing liquid.
[0145] FIG. 26 is a chart showing the washing efficiency using the moving magnetic field washing technique as described herein for the purpose of confirming the subject matter of the present disclosure and comparing it with the King-Fisher washing technique. By way of example and not by way of limitation, in one embodiment, the analyte of interest of the HIV Ab p24 assay is analyzed. The sample droplets can be mixed with paramagnetic beads, for example MS300 beads. Each assessment of washing efficiency can include two bars in the chart. For example, bar 1 and bar 2 represent the negative and positive signals received during detection. By way of example and not by way of limitation, the bars with odd numbers (1, 3, 5 and 7) represent the negative signals received during each assessment. The lower the negative signals received, the higher the washing efficiency. By way of example, assessment 2601 represents the signal received without magnetic field movement, and assessment 2602 represents the signal received after magnetic field movement in the vertical direction. By way of example, the signal percentage is a unit of measurement when digital detection is performed and can be calculated by dividing the number of positive nanowells by the number of microparticles in the detection compartment. Evaluation 2601 received a signal of 0.14% and evaluation 2602 received a signal of 0.08%. By way of example, evaluations 2603 and 2604 are evaluations of one and three washes, respectively, using the King-Fisher method. Each of these received a signal of 0.08%. By way of example and not by way of limitation, washing the mixed sample droplets using a moving vertical magnetic field improves the washing efficiency to a level comparable to the King-Fisher washing method.
[0146] 27A-27B show an exemplary bead loading technique using a moving magnetic field as described herein. In one embodiment, the exemplary technique may involve seeding and sealing a single bead or microparticle conjugated with an analyte and enzyme sandwich as described herein into a single well filled with a chemical solution (also referred to herein as a substrate).
[0147] As shown in FIG. 27A, an exemplary bead loading technique 2700 can include substrate filling 2710, microparticle seeding 2720, and inert liquid sealing 2730. At 2710, a substrate solution 2701 is prepared, which can include a phosphate-based material and a wash buffer. The substrate 2701 can be configured to activate a fluorescent signal from microparticles 2704 containing an analyte of interest for detection, as described further herein. Referring to FIG. 27A, by way of example and not by way of limitation, the substrate solution 2701 is introduced in an area adjacent to the microwell array 2702 prior to seeding of the microparticles 2704. In one embodiment, a compartment above the microwell array 2702 is flooded with the substrate solution 2701, which fills one or more of the microwells of the microwell array 2702. The surface of the microwell array 2702 can be hydrophilic with respect to the substrate solution 2701 such that, when introduced to the microwell array 2702, each microwell 2703 becomes filled with substrate 2701. Wetting of the surface of the microwell array 2702 by the substrate liquid can facilitate migration of microparticles 2704 across the microwell array surface 2702 as further described herein.
[0148] With further reference to FIG. 27A, at 2720, microparticles 2704 are seeded into the microwell array. A magnet (not shown) moves the conjugated microparticles 2704, which are sized to fit within the microwells, into the microwell array chamber 2706 along with auxiliary microparticles 2705 (if used). The auxiliary microparticles 2705 can be provided to aid in microparticle transport. By way of example and not limitation, in one embodiment, the auxiliary microparticles 2705 can have a size of 10 μm, which is larger than the 2.8 μm functional microparticles 2704 and the 4.5 μm microwells 7203 in this example, thus preventing the auxiliary microparticles 2705 from becoming seeded into the microwells 2703. The magnetic field can be configured to introduce most or all of the microparticles 2704 into the microwells 2703 and / or remove the remaining microparticles 2704 and auxiliary microparticles 2705 (if used) from the array surface 2702. After the microparticles 2704 have been seeded into the microwells 2703, some excess microparticles 2704 and / or auxiliary microparticles 2705 (if used) may remain on the top surface 2702 of the array.
[0149] 27A , inert liquid sealing is performed in which an inert liquid, such as oil, is introduced into the microwell chambers to form an array of sealed microwells containing a volume of substrate fluid and a single microbead 2704. For example, but not by way of limitation, in one embodiment, the inert liquid or oil 2731 may include 3M Fluorinert™ FC-40. In one embodiment, the oil 2731 may be drawn into the microwell chambers by negative pressure from a negative pressure source located on the opposite side of the chamber from which the oil is introduced. The oil 2731 may further remove excess microparticles 2704 and auxiliary microparticles 2705 (if used) from the top of the microwell array and seal individual microwells 2703 prior to incubation (if performed) and detection, including imaging of microparticles 2703 as described herein. Parameters that may affect oil sealing 2730 include the magnetic field applied during seeding 2720, the surface characteristics of the microwell array 2702, the liquid properties of the substrate 2701 and oil 2731, the amount of functional microparticles 2704 and auxiliary microparticles 2705 (if used), seeding efficiency, and oil sealing flow rate.
[0150] 27B, an example of a microwell array having sealed and unsealed wells is shown to further illustrate the advantages of the exemplary bead loading techniques, including seeding and sealing of the wells as described herein. On the left, a sealed well filled with substrate 2701 is shown containing a single active microparticle 2704. Substrate 2701 can be configured to activate a fluorescent signal from active microparticle 2704 containing an analyte of interest for detection, and the sealed well can separate microparticle 2704 from other microparticles so that single microparticles 2704 containing single molecules of the analyte of interest can be counted.
[0151] With further reference to FIG. 27B, to the right of the sealed wells, a first pair of unsealed wells, one of which contains a single active particulate 2704, is shown with substrate 2701 pooled above the microarray surface 2702 and between the pair of unsealed wells. Thus, when the fluorescent signal from the active particulate 2704 is activated by substrate 2701, the fluorescent signal can leak into the pool of substrate 2701 above the array surface 2702 toward adjacent wells, thereby causing a false fluorescent signal to be detected. The false fluorescent signal can prevent single molecules of the analyte of interest from being counted, for example, due to noise or interference caused by the fluorescent signal leaking from the microwell containing the particle onto the surface of the microarray 2702 and / or into adjacent wells. For example, but not limited to, the pool of substrate can cause a blurred or cloudy image of the resulting array, which can prevent or inhibit a determination of whether an individual particulate 2704 is active.
[0152] 27B, to the right of the first pair of unsealed wells, a second pair of unsealed wells is shown with substrate 2701 pooled above the microarray surface 2702 and between the second pair of unsealed wells, one of which contains a single inactive particle 2704. The pooling of substrate between the second pair of unsealed wells may further cause noise or interference caused by blocking other fluorescent signals from adjacent wells. For example, but not by way of limitation, the pooling of substrate may cause a blur or haze in the resulting image of the array, which may be at least in part due to fluorescent interference from adjacent wells and / or from unbound material in the substrate, which may prevent or inhibit a determination of whether a particle 2704 is inactive. By way of example and not by way of limitation, in one embodiment, a microarray 2702 having sealed wells may reduce noise in detected images of active and inactive particle 2704 in the array, thereby improving the signal-to-noise ratio of the detection system.
[0153] Although the subject matter of the present disclosure has been described herein with respect to certain preferred embodiments, those skilled in the art will recognize that various modifications and improvements can be made to the subject matter of the present disclosure without departing from the scope of the subject matter of the present disclosure. Also, although individual features of one embodiment of the subject matter of the present disclosure may be described herein or shown in the drawings of one embodiment and not shown in other embodiments, it will be apparent that individual features of one embodiment can be combined with one or more features of another embodiment or with features from multiple embodiments.
[0154] In addition to the specific embodiments claimed below, the subject matter of the present disclosure is also directed to other embodiments having the dependent features claimed below and any other possible combinations of the features disclosed above. Thus, the specific features set forth in the dependent claims and disclosed above can be combined with each other in other ways within the scope of the subject matter of the present disclosure, and thus the subject matter of the present disclosure should be considered to be expressly directed to other embodiments having any other possible combinations. Thus, the above descriptions of specific embodiments of the subject matter of the present disclosure are presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the subject matter of the present disclosure to the disclosed embodiments. It will be apparent to those skilled in the art that various modifications and variations can be made to the method and system of the presently disclosed subject matter without departing from the spirit or scope of the presently disclosed subject matter. Thus, it is intended that the presently disclosed subject matter cover modifications and variations that come within the scope of the appended claims and their equivalents.
Claims
1. 1. An assay surface (AS) for the analysis of an analyte of interest in a sample, comprising: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; and a detection component configured to receive the plurality of solid supports by said magnetic force and detect the presence of said analyte or determine the level or concentration of said analyte.
2. The AS of claim 1 , wherein the plurality of solid supports comprises magnetic or paramagnetic microparticles or beads.
3. 2. The AS of claim 1, wherein at least one of said plurality of solid supports specifically binds said analyte of interest or at least one reagent or conjugate.
4. The AS of claim 1 , wherein said sample processing components further comprise said plurality of solid supports in said at least one storage area.
5. 2. The AS of claim 1, wherein the sample processing component further comprises at least one mixing area configured to mix the plurality of solid supports, the analytes of interest, and at least one reagent or conjugate.
6. The AS of claim 5 , wherein the sample processing component further comprises the at least one reagent or conjugate in the at least one mixing area.
7. The AS of claim 5 , wherein the at least one mixing area has a volume capacity of about 25 μL or less.
8. 6. The AS of claim 5, wherein the at least one reagent is selected from the group consisting of a detectable label, a binding member, a dye, a surfactant, a diluent, and combinations thereof.
9. The AS of claim 8 , wherein the binding member comprises a receptor or an antibody.
10. 6. The AS of claim 5, wherein the at least one wash area is configured to wash away any molecules that are not bound to any solid support.
11. The AS of claim 10, wherein the at least one wash area has a volume capacity of about 10 μL or less.
12. The AS of claim 1 , wherein the assay surface comprises a plurality of channels, each of the plurality of channels being between a first sample preparation area and a second sample preparation area.
13. 13. The AS of claim 12, wherein the assay surface comprises a plurality of stopping elements, at least one of the plurality of stopping elements being between the first sample preparation area and the second sample preparation area.
14. The AS of claim 13 , wherein when the at least one stop element is removed, the liquid body in the first region is fluidly connected with the liquid body in the second region.
15. The AS of claim 10, wherein the plurality of solid supports are moved into the detection component under the magnetic force after passing through the at least one washing region.
16. The AS of claim 1 , wherein the detection component is configured for optical detection, analog detection, or digital detection.
17. 2. The AS of claim 1, wherein the detection component comprises an array of elements, each element of the array of elements being dimensioned to hold a single solid support of the plurality of solid supports.
18. 20. The AS of claim 17, wherein the array of elements comprises an array of nanowells.
19. 2. The AS of claim 1, wherein the detection component is further configured to receive a substrate fluid, the substrate fluid configured to provide a detectable signal from the plurality of solid supports, and the detection component is further configured to receive an inert liquid, the inert liquid configured to seal each element of the array of elements containing a portion of the substrate fluid and a single solid support of the plurality of solid supports.
20. 20. The AS of claim 19, wherein the inert liquid comprises an oil.
21. The AS of claim 1 , wherein the detection component is configured to acquire an image of the array of elements after the plurality of solid supports are moved into the detection component.
22. The AS of claim 1 , wherein the detection component is configured for single molecule counting.
23. The AS of claim 1 , wherein the assay surface comprises a hydrophobic material.
24. 2. The AS of claim 1, wherein the assay surface further comprises a plurality of liquid bodies, a plurality of solid supports and at least one reagent or conjugate in the plurality of sample preparation areas.
25. An assay processing unit (APU) for performing sample processing and analyte detection on an assay surface comprising a sample processing component and a detection component, an assay surface receiving component configured to receive and hold the assay surface; a magnetic element configured to generate a magnetic field, the magnetic field being movable along the assay surface when the assay surface is received by the receiving component; and one or more processors configured to use the magnetic field to move at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component and to the detection component of the assay surface.
26. The APU of claim 25 , wherein the magnetic element comprises a magnet.
27. 27. The APU of claim 26, further comprising a sliding element configured to move the magnetic element under the control of the one or more processors along a horizontal direction relative to a plane defined by an upper surface of the assay surface when the assay surface is received by the receiving component.
28. The APU of claim 27 , wherein the sliding element comprises a motor.
29. The APU of claim 26, further comprising a drive element configured to move the magnetic element under the control of the one or more processors in a direction perpendicular to a plane defined by an upper surface of the assay surface when the assay surface is received by the receiving component.
30. The APU of claim 29 , wherein the drive element comprises a motor or a string.
31. The APU of claim 25 , wherein the magnetic element comprises an electromagnet configured to generate a movable magnetic field.
32. 26. The APU of claim 25, further comprising a mixing dynamics element controlled by the one or more processors configured to mix at least one liquid body in at least one region of the assay surface under a predetermined frequency when the assay surface is received by the receiving component.
33. The APU of claim 32 , wherein the mixed dynamics element comprises a vibration motor or an electromagnet.
34. 26. The APU of claim 25, wherein when the assay surface is accepted by the accepting component, the one or more processors control the detection component of the assay surface to acquire an image of the detection component.
35. 1. An assay processing system (APS) for analysis of an analyte of interest in a sample, comprising one or more assay surfaces and an assay processing unit (APU), said at least one assay surface comprising: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; a detection component configured to receive the plurality of solid supports by the magnetic force and detect the presence of the analyte or determine the level or concentration of the analyte; The APU, an assay surface receiving component configured to receive and hold the one or more assay surfaces; a magnetic element configured to generate a magnetic field, the magnetic field being movable along the at least one assay surface when the at least one assay surface is received by the receiving component; and one or more processors configured to use the magnetic field to move at least one solid support disposed on the assay surface, through at least one liquid body in at least one region of the sample processing component, and to the detection component of the assay surface. Assay Processing System (APS).
36. The APS of claim 35, comprising at least one assay surface according to any one of claims 1 to 24.
37. The APS according to claim 35, comprising at least one APU according to any one of claims 25 to 34.
38. 1. A laboratory system for analysis of one or more analytes of interest in a plurality of samples, comprising: one or more assay processing systems (APS), said at least one APS including one or more assay surfaces and an assay processing unit (APU); said at least one assay surface comprising: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; a detection component configured to receive the plurality of solid supports by the magnetic force and detect the presence of the analyte or determine the level or concentration of the analyte; The APU is an assay receiving component configured to receive and hold the one or more assay surfaces; a magnetic element configured to generate a magnetic field, the magnetic field being movable along the at least one assay surface when the at least one assay surface is received by the receiving component; one or more processors configured to move a magnetic field to urge at least one solid support disposed on said at least one assay surface through at least one liquid body in at least one region of said sample processing component and to said detection component of said assay surface using said magnetic field; a controller configured to control a plurality of the one or more APSs to process corresponding samples and to detect the presence of at least one corresponding analyte or to determine the level or concentration of at least one corresponding analyte in a substantially parallel manner. Laboratory systems.
39. 34. A laboratory system according to claim 33, comprising at least one assay surface comprising an assay surface according to any one of claims 1 to 24.
40. A laboratory system according to claim 33, comprising at least one APU comprising an APU according to any one of claims 25 to 34.
41. 39. The laboratory system of claim 38, wherein the laboratory system is configured to perform one or more of an HIV p24 assay, a HBsAg assay, a Troponin I assay, a TSH assay, a myoglobin assay, a PSA assay, a BNP assay, a PIVKA-II assay, a HIV Ab assay, an estradiol assay, and a COVID-Ag assay.
42. 40. The laboratory system of claim 38, wherein the laboratory system has a throughput of at least 360 samples per hour.
43. 40. The laboratory system of claim 38, wherein the laboratory system has a throughput of at least 375 samples per hour per square meter of footprint of the laboratory system.
44. 1. A method for the analysis of an analyte of interest in a sample, comprising: below: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; a detection component configured to receive the plurality of solid supports by the magnetic force and detect the presence of the analyte or determine the level or concentration of the analyte; loading at least one liquid body into at least one wash region of an assay surface comprising: loading the detection component with at least one liquid body; loading a liquid body containing the analyte into the sample processing component; and detecting said analyte of interest in said detection component.
45. 45. The method of claim 44, wherein the sample processing component comprises a plurality of solid supports, the method further comprising moving the plurality of solid supports under the magnetic force through the plurality of sample preparation regions and into the detection component prior to detection of the analyte of interest in the detection component.
46. loading a plurality of solid supports into said sample processing component; 45. The method of claim 44, further comprising moving the plurality of solid supports under the magnetic force through the plurality of sample preparation regions and into the detection component prior to detection of the analytes of interest in the detection component.
47. The method of claim 44, wherein the assay surface comprises an assay surface according to any one of claims 1 to 24.
48. 1. A method for performing sample processing and analyte detection on an assay surface comprising a sample processing component and a detection component using an assay processing unit (APU), comprising: receiving an assay surface into an assay surface receiving component of said APU; generating a magnetic field movable along the assay surface by a magnetic element of the APU; detecting the analyte of interest in the detection component controlled by one or more processors of the APU.
49. 49. The method of claim 48, wherein the assay surface comprises a plurality of solid supports, the method further comprising: moving the magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component using the magnetic field to the detection component of the assay surface prior to detection of the analyte of interest in the detection component.
50. loading a plurality of solid supports onto said sample processing component; 49. The method of claim 48, comprising: moving the magnetic field controlled by one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using the magnetic field prior to detection of the analyte of interest in the detection component.
51. The method of claim 48, wherein the assay surface comprises an assay surface according to any one of claims 1 to 24.
52. The method of claim 48, wherein the APU comprises an APU according to any one of claims 23 to 34.
53. 1. A method of analysis of an analyte of interest in a sample using an assay processing system (APS) comprising one or more assay surfaces and an assay processing unit (APU), comprising: below: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; a detection component configured to receive the plurality of solid supports by the magnetic force and detect the presence of the analyte or determine the level or concentration of the analyte; loading at least one liquid body into at least one wash region of at least one assay surface; loading at least one liquid body into said detection component; loading a liquid body containing the analyte into the sample processing component; receiving said at least one assay surface into an assay surface receiving component of said APU; generating a magnetic field movable along the assay surface by a magnetic element of the APU; and detecting the analyte of interest in the detection component controlled by one or more processors of the APU.
54. 54. The method of claim 53, wherein the at least one assay surface comprises a plurality of solid supports, the method further comprising, prior to detection of the analyte, moving the magnetic field controlled by the one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using the magnetic field.
55. loading a plurality of solid supports onto said assay surface; 54. The method of claim 53, comprising: prior to detection of the analyte, moving the magnetic field controlled by the one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using the magnetic field.
56. The method of claim 53, wherein the assay surface comprises an assay surface according to any one of claims 1 to 24.
57. The method of claim 53, wherein the APU comprises an APU according to any one of claims 25 to 34.
58. 1. A method of using a laboratory system for analysis of one or more analytes of interest in a plurality of samples, said laboratory system including one or more assay processing systems (APS) and a controller, at least one APS including one or more assay surfaces and an assay surface processing unit (APU), said method comprising: below: a sample processing component configured to process the sample for detection, the sample processing component including a plurality of sample preparation areas including at least one wash area configured to hold a body of liquid and at least one storage area configured to hold a plurality of solid supports, the plurality of solid supports being movable through the plurality of sample preparation areas under a magnetic force; a detection component configured to receive the plurality of solid supports by the magnetic force and detect the presence of the analyte or determine the level or concentration of the analyte; loading at least one body of liquid into at least one wash region of at least one assay surface; loading at least one liquid body into the detection component; loading a liquid body containing the analyte into the sample processing component; receiving said at least one assay surface into an assay surface receiving component of a corresponding APU; generating, by a magnetic element of the APU, a magnetic field movable along the at least one assay surface; and detecting the analyte of interest in the detection component controlled by one or more processors of the corresponding APU; The method, wherein the controller is configured to control a plurality of APSs of the one or more APSs to perform corresponding steps on corresponding samples and to detect the presence of at least one corresponding analyte or determine the level or concentration of at least one corresponding analyte in substantially parallel.
59. 59. The method of claim 58, wherein the at least one assay surface comprises a plurality of solid supports, the method further comprising, prior to detection of the analyte, moving the magnetic field controlled by the one or more processors of the APU to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface using the magnetic field.
60. loading a plurality of solid supports onto said at least one assay surface; 59. The method of claim 58, comprising: moving the magnetic field controlled by the one or more processors of the APU to use the magnetic field to urge at least one solid support disposed on the assay surface through at least one liquid body in at least one region of the sample processing component to the detection component of the assay surface prior to detection of the analyte.
61. 59. The method of claim 58, wherein at least one assay surface comprises an assay surface according to any one of claims 1 to 24.
62. 59. The method of claim 58, wherein at least one APU comprises an APU according to any one of claims 25 to 34.
63. 59. The method of claim 58, wherein the laboratory system is configured to perform one or more of an HIV p24 assay, a HBsAg assay, a troponin I assay, a TSH assay, a myoglobin assay, a PSA assay, a BNP assay, a PIVKA-II assay, a HIV Ab assay, an estradiol assay, and a COVID-Ag assay.
64. 60. The method of claim 58, wherein the laboratory system has a throughput of at least 360 samples per hour.
65. 60. The method of claim 58, wherein the laboratory system has a throughput of at least 375 samples per hour per square meter of footprint of the laboratory system.
66. 1. A laboratory system for high throughput analysis of an analyte of interest in a sample, comprising: a sample processing component configured to process a sample for detection, the sample processing component configured to obtain a level or concentration of an analyte in the sample, or a level or concentration of a conjugate indicative of the analyte in the sample, suitable for detection; a detection component configured to detect the presence of the analyte in the sample; The laboratory system has a time to result of less than 6 minutes, or a time to result in the range of 3 to 5 minutes, or a time to result in the range of 3 to 7 minutes.
67. 1. A laboratory system for high throughput analysis of an analyte of interest in a sample, comprising: a sample processing component configured to process a sample for detection, the sample processing component configured to obtain a level or concentration of an analyte in the sample, or a level or concentration of a conjugate indicative of the analyte in the sample, suitable for detection; a detection component configured to detect the presence of the analyte in the sample; 13. A laboratory system, wherein the laboratory system has a throughput of at least 360 samples per hour.
68. 1. A laboratory system for high throughput analysis of an analyte of interest in a sample, comprising: a sample processing component configured to process a sample for detection, the sample processing component configured to obtain a level or concentration of an analyte in the sample, or a level or concentration of a conjugate indicative of the analyte in the sample, suitable for detection; a detection component configured to detect the presence of the analyte in the sample; 10. The laboratory system, wherein the laboratory system has a throughput of at least 375 samples per hour per square meter of footprint of the laboratory system, or in the range of 375-600 samples per hour per square meter of footprint of the laboratory system.
69. 1. A method for high throughput analysis of an analyte of interest in a sample, comprising: processing the sample for detection, which comprises obtaining a level or concentration of an analyte in said sample, or a level or concentration of a conjugate indicative of said analyte in said sample, suitable for detection; detecting the presence of the analyte in the sample; The method, wherein processing the sample and detecting the presence of the analyte in the sample is completed in less than 6 minutes, or in the range of 3-5 minutes, or in the range of 3-7 minutes for the sample.
70. 1. A method for high throughput analysis of an analyte of interest in a sample, comprising: processing the sample for detection, which comprises obtaining a level or concentration of an analyte in said sample, or a level or concentration of a conjugate indicative of said analyte in said sample, suitable for detection; detecting the presence of the analyte in the sample; The method, wherein processing the samples and detecting the presence of the analyte in the samples is completed at least 360 samples per hour.
71. 1. A method for high throughput analysis of an analyte of interest in a sample, comprising: processing the sample for detection, which comprises obtaining a level or concentration of an analyte in said sample, or a level or concentration of a conjugate indicative of said analyte in said sample, suitable for detection; detecting the presence of the analyte in the sample; wherein processing the samples and detecting the presence of the analyte in the samples is completed within at least 375 samples per hour per square meter of the laboratory system or within the range of 375-600 samples per hour per square meter of footprint of the laboratory system.
Citation Information
Patent Citations
Droplet-based biochemistry
JP2009534653A
Ultra-high sensitivity detection of molecules or particles using beads or other traps.
JP2013521499A
Devices and methods for sample analysis
JP2020502478A
Droplet-based surface modification and washing
US20070243634A1
Method for using magnetic particles in droplet microfluidics
US20090283407A1
